RxNorm Semantic Concepts Index - 267
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "267".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2670 | Methyl morphine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2670 | Methyl morphine | Designated preferred name (PT) | YES | |
| RxCUI: 2670 | Methyl morphine | Full form of descriptor (FN) | YES | |
| RxCUI: 2670 | Methyl morphine | Designated preferred name (PT) | YES | |
| RxCUI: 2670 | Methyl morphine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670 | Methyl morphine | Full form of descriptor (FN) | YES | |
| RxCUI: 26700 | Hb 146(HC3), His-pro | British preferred term (PTGB) | NO | |
| RxCUI: 26700 | Hb 146(HC3), His-pro | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26700 | Hb 146(HC3), His-pro | Designated preferred name (PT) | NO | |
| RxCUI: 26700 | Hb 146(HC3), His-pro | Full form of descriptor (FN) | NO | |
| RxCUI: 2670038 | Magnolia champaca flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2670080 | Cordia dichotoma whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2670081 | Geranium robertianum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 26701 | Hemoglobin Zurich | British preferred term (PTGB) | NO | |
| RxCUI: 26701 | Hemoglobin Zurich | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26701 | Hemoglobin Zurich | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26701 | Hemoglobin Zurich | Designated preferred name (PT) | NO | |
| RxCUI: 26701 | Hemoglobin Zurich | Full form of descriptor (FN) | NO | |
| RxCUI: 26701 | Hemoglobin Zurich | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670160 | California intense cedar pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670160 | California intense cedar pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2670162 | salicylic acid 12 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670162 | salicylic acid 12 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670162 | salicylic acid 12 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670163 | crizotinib 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670164 | crizotinib Pellet Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670165 | crizotinib Oral Pellet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2670166 | crizotinib 150 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670166 | crizotinib 150 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670167 | crizotinib 150 MG [Xalkori] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670168 | Xalkori Pellet Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670169 | crizotinib Oral Pellet [Xalkori] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2670170 | XALKORI 150 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670170 | XALKORI 150 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670170 | XALKORI 150 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670171 | crizotinib 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670172 | crizotinib 20 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670172 | crizotinib 20 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670173 | crizotinib 20 MG [Xalkori] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670174 | XALKORI 20 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670174 | XALKORI 20 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670174 | XALKORI 20 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670175 | crizotinib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670176 | crizotinib 50 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670176 | crizotinib 50 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670177 | crizotinib 50 MG [Xalkori] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670178 | XALKORI 50 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670178 | XALKORI 50 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670178 | XALKORI 50 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670179 | fruquintinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2670180 | fruquintinib 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670181 | fruquintinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670182 | fruquintinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670183 | fruquintinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2670184 | fruquintinib 1 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670184 | fruquintinib 1 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670185 | Fruzaqla | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2670186 | fruquintinib 1 MG [Fruzaqla] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670187 | Fruzaqla Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670188 | Fruzaqla Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670189 | fruquintinib Oral Capsule [Fruzaqla] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2670190 | Fruzaqla 1 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670190 | Fruzaqla 1 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670190 | Fruzaqla 1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670195 | fruquintinib 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670196 | fruquintinib 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670196 | fruquintinib 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670197 | fruquintinib 5 MG [Fruzaqla] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670198 | Fruzaqla 5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670198 | Fruzaqla 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670198 | Fruzaqla 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670200 | zinc gluconate 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2670201 | zinc gluconate Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2670202 | zinc gluconate Oral Spray Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2670203 | zinc gluconate Oral Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2670204 | zinc gluconate 1.5 % Oral Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670204 | zinc gluconate 1.5 % Oral Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670204 | zinc gluconate 1.5 % Oral Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670205 | Eucalyptus oil / menthol Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2670206 | eucalyptus oil 5 % / menthol 10 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670206 | eucalyptus oil 5 % / menthol 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670206 | eucalyptus oil 5 % / menthol 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670285 | apadamtase Alfa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2670285 | apadamtase Alfa | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670286 | ADAMTS13, recombinant-krhn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2670287 | ADAMTS13, recombinant-krhn 1500 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670288 | ADAMTS13, recombinant Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670289 | ADAMTS13, recombinant Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2670293 | ADAMTS13, recombinant-krhn 1500 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670293 | ADAMTS13, recombinant-krhn 1500 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670294 | Adzynma | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2670295 | ADAMTS13, recombinant-krhn 1500 UNT [Adzynma] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670296 | Adzynma Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670297 | ADAMTS13, recombinant Injection [Adzynma] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2670300 | ADZYNMA 1500 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670300 | ADZYNMA 1500 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670300 | ADZYNMA 1500 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670302 | Uribel Tabs | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2670303 | benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG [Uribel Tabs] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670304 | Uribel Tabs Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670305 | Uribel Tabs Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670306 | benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Oral Tablet [Uribel Tabs] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2670308 | Uribel Tabs 81.6 MG / 9 MG / 36.2 MG / 10.8 MG / 0.12 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670308 | Uribel Tabs 81.6 MG / 9 MG / 36.2 MG / 10.8 MG / 0.12 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670308 | Uribel Tabs 81.6 MG / 9 MG / 36.2 MG / 10.8 MG / 0.12 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670310 | ADAMTS13, recombinant-krhn 500 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670311 | ADAMTS13, recombinant-krhn 500 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670311 | ADAMTS13, recombinant-krhn 500 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670312 | ADAMTS13, recombinant-krhn 500 UNT [Adzynma] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670313 | ADZYNMA 500 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670313 | ADZYNMA 500 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670313 | ADZYNMA 500 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670319 | forsythiaside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2670320 | Brassica rapa subsp. oleifera whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2670341 | talinexomer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 267035 | metoclopramide dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 267036 | Metoclopramide chlorhydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 267036 | Metoclopramide chlorhydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 267036 | Metoclopramide chlorhydrate | Designated preferred name (PT) | YES | |
| RxCUI: 267036 | Metoclopramide chlorhydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 2670389 | tramadol hydrochloride 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670389 | tramadol hydrochloride 25 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2670390 | traMADol hydrochloride 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670390 | traMADol hydrochloride 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670390 | traMADol hydrochloride 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2670391 | menthol 3.5 % / methyl salicylate 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670391 | menthol 3.5 % / methyl salicylate 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670391 | menthol 3.5 % / methyl salicylate 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670392 | camphor 3.5 % / menthol 3 % / methyl salicylate 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670392 | camphor 3.5 % / menthol 3 % / methyl salicylate 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670392 | camphor 3.5 % / menthol 3 % / methyl salicylate 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670393 | micafungin 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670395 | micafungin 100 MG [Mycamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670397 | micafungin 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670399 | micafungin 50 MG [Mycamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670401 | diclofenac 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670403 | diclofenac 25 MG [Zipsor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670442 | Zituvio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2670443 | sitagliptin 100 MG [Zituvio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670443 | sitagliptin 100 MG [Zituvio] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2670444 | Zituvio Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670445 | Zituvio Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670446 | sitagliptin Oral Tablet [Zituvio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2670446 | sitagliptin Oral Tablet [Zituvio] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2670447 | Zituvio 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670447 | Zituvio 100 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2670447 | Zituvio 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670447 | Zituvio 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670448 | sitagliptin 25 MG [Zituvio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670448 | sitagliptin 25 MG [Zituvio] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2670449 | Zituvio 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670449 | Zituvio 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2670449 | Zituvio 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670449 | Zituvio 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670450 | sitagliptin 50 MG [Zituvio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670450 | sitagliptin 50 MG [Zituvio] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2670451 | Zituvio 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670451 | Zituvio 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2670451 | Zituvio 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670451 | Zituvio 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670452 | stearoyl inulin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2670453 | Taurolidine | Full form of descriptor (FN) | YES | |
| RxCUI: 2670453 | Taurolidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2670453 | Taurolidine | Designated preferred name (PT) | YES | |
| RxCUI: 2670453 | Taurolidine | Full form of descriptor (FN) | YES | |
| RxCUI: 2670453 | Taurolidine | Designated preferred name (PT) | YES | |
| RxCUI: 2670454 | tetrahydrocurcumin .beta.-o-glucuronide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2670455 | taurolidine 13.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670456 | heparin / taurolidine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2670457 | heparin / taurolidine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670458 | heparin / taurolidine Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2670461 | heparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG in 3 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670461 | heparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG in 3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670461 | heparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670462 | heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670462 | heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670463 | Defencath | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2670464 | heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML [Defencath] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670465 | Defencath Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670466 | heparin / taurolidine Injection [Defencath] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2670468 | DEFENCATH 3000 UNT / 40.5 MG in 3 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670468 | DEFENCATH 3000 UNT / 40.5 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670468 | DEFENCATH 3000 UNT / 40.5 MG in 3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670469 | DEFENCATH 1000 UNT / 13.5 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670469 | DEFENCATH 1000 UNT / 13.5 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670469 | DEFENCATH 1000 UNT / 13.5 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2670470 | dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670470 | dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670470 | dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670470 | dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670470 | dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670471 | heparin sodium, porcine 5,000 UNT / taurolidine 67.5 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670471 | heparin sodium, porcine 5,000 UNT / taurolidine 67.5 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670471 | heparin sodium, porcine 5,000 UNT / taurolidine 67.5 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670472 | DEFENCATH 5000 UNT / 67.5 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670472 | DEFENCATH 5000 UNT / 67.5 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670472 | DEFENCATH 5000 UNT / 67.5 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670532 | phenylephrine hydrochloride, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2670534 | choline / dextromethorphan / guaifenesin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2670534 | choline / dextromethorphan / guaifenesin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670535 | choline / dextromethorphan / guaifenesin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2670535 | choline / dextromethorphan / guaifenesin Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670536 | choline / dextromethorphan / guaifenesin Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2670536 | choline / dextromethorphan / guaifenesin Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670537 | choline / dextromethorphan / guaifenesin Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2670537 | choline / dextromethorphan / guaifenesin Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670538 | choline salicylate / dextromethorphan hydrobromide / guaifenesin Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670539 | choline salicylate / dextromethorphan hydrobromide / guaifenesin Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670540 | choline salicylate / dextromethorphan hydrobromide / guaifenesin Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670541 | choline salicylate 870 MG / dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 30 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670541 | choline salicylate 870 MG / dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 30 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670541 | choline salicylate 870 MG / dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 30 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670541 | choline salicylate 870 MG / dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670541 | choline salicylate 870 MG / dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 30 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670542 | choline / guaifenesin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2670542 | choline / guaifenesin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670543 | choline / guaifenesin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2670543 | choline / guaifenesin Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670544 | choline / guaifenesin Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2670544 | choline / guaifenesin Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670545 | choline / guaifenesin Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2670545 | choline / guaifenesin Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670546 | choline salicylate / guaifenesin Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670547 | choline salicylate / guaifenesin Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670548 | choline salicylate / guaifenesin Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670549 | choline salicylate 870 MG / guaiFENesin 200 MG in 30 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670549 | choline salicylate 870 MG / guaiFENesin 200 MG in 30 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670549 | choline salicylate 870 MG / guaiFENesin 200 MG in 30 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670549 | choline salicylate 870 MG / guaiFENesin 200 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670549 | choline salicylate 870 MG / guaiFENesin 200 MG in 30 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670550 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670551 | Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670552 | Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670553 | Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670554 | meningococcal group B vaccine / Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2670555 | meningococcal group B vaccine / Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670556 | meningococcal group B vaccine / Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2670559 | Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Tetanus Toxoid Conjugate Vaccine 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670559 | Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Tetanus Toxoid Conjugate Vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670559 | Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Tetanus Toxoid Conjugate Vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670560 | Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Tetanus Toxoid Conjugate Vaccine Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670560 | Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Tetanus Toxoid Conjugate Vaccine Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670561 | Penbraya | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2670562 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML [Penbraya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670563 | Penbraya Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670564 | meningococcal group B vaccine / Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine Injection [Penbraya] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2670566 | PENBRAYA vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670566 | PENBRAYA vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670566 | PENBRAYA vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670566 | PENBRAYA vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670567 | PENBRAYA vaccine Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2670567 | PENBRAYA vaccine Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670567 | PENBRAYA vaccine Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670598 | acetaminophen 500 MG / dextromethorphan hydrobromide 20 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670598 | acetaminophen 500 MG / dextromethorphan hydrobromide 20 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670598 | acetaminophen 500 MG / dextromethorphan hydrobromide 20 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670599 | Darunavir propylene glycolate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2670599 | Darunavir propylene glycolate | Designated preferred name (PT) | YES | |
| RxCUI: 2670599 | Darunavir propylene glycolate | Full form of descriptor (FN) | YES | |
| RxCUI: 2670600 | octylphenoxyethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2670601 | lidocaine HCl 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670601 | lidocaine HCl 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670601 | lidocaine HCl 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670602 | ferrous sulfate 175 MG (iron 35 MG) / folic acid 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670602 | ferrous sulfate 175 MG (iron 35 MG) / folic acid 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670602 | ferrous sulfate 175 MG (iron 35 MG) / folic acid 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670602 | ferrous sulfate 175 MG (iron 35 MG) / folic acid 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670628 | immunoglobulin G, human 20 % in 50 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670628 | immunoglobulin G, human 20 % in 50 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670628 | immunoglobulin G, human 20 % in 50 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670628 | immunoglobulin G, human 20 % in 50 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670628 | immunoglobulin G, human 20 % in 50 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670629 | Hizentra 20 % in 50 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670629 | Hizentra 20 % in 50 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670629 | Hizentra 20 % in 50 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670629 | Hizentra 20 % in 50 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670629 | Hizentra 20 % in 50 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670630 | efbemalenograstim alfa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2670631 | nirogacestat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2670632 | nirogacestat hydrobromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2670633 | nirogacestat 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670634 | nirogacestat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670635 | nirogacestat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670636 | nirogacestat Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2670637 | nirogacestat 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670637 | nirogacestat 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670637 | nirogacestat 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670638 | Ogsiveo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2670639 | nirogacestat 50 MG [Ogsiveo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670640 | Ogsiveo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670641 | Ogsiveo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670642 | nirogacestat Oral Tablet [Ogsiveo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2670643 | Ogsiveo 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670643 | Ogsiveo 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670643 | Ogsiveo 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670643 | Ogsiveo 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670644 | repotrectinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2670645 | repotrectinib 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670646 | repotrectinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670647 | repotrectinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670648 | repotrectinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2670649 | repotrectinib 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670649 | repotrectinib 40 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670650 | Augtyro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2670651 | repotrectinib 40 MG [Augtyro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670652 | Augtyro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670653 | Augtyro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670654 | repotrectinib Oral Capsule [Augtyro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2670655 | AUGTYRO 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670655 | AUGTYRO 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670655 | AUGTYRO 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670656 | efbemalenograstim alfa-vuxw | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2670657 | efbemalenograstim alfa-vuxw 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670658 | efbemalenograstim alfa Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2670659 | efbemalenograstim alfa Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2670662 | efbemalenograstim alfa-vuxw 20 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670662 | efbemalenograstim alfa-vuxw 20 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670662 | efbemalenograstim alfa-vuxw 20 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670663 | efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670664 | Ryzneuta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2670665 | efbemalenograstim alfa-vuxw 20 MG/ML [Ryzneuta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670666 | Ryzneuta Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2670667 | efbemalenograstim alfa Prefilled Syringe [Ryzneuta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2670669 | Ryzneuta 20 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670669 | Ryzneuta 20 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670669 | Ryzneuta 20 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670669 | Ryzneuta 20 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670670 | efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe [Ryzneuta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2670670 | efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe [Ryzneuta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670674 | acetaminophen / diphenhydramine Powder for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2670674 | acetaminophen / diphenhydramine Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670675 | acetaminophen / diphenhydramine hydrochloride Oral Powder Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2670676 | acetaminophen / diphenhydramine hydrochloride Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670677 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670677 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670677 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670677 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670677 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670677 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670677 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670677 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670677 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG Powder for Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2670678 | acetaminophen 650 MG / dextromethorphan HBr 20 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670678 | acetaminophen 650 MG / dextromethorphan HBr 20 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670678 | acetaminophen 650 MG / dextromethorphan HBr 20 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2670678 | acetaminophen 650 MG / dextromethorphan HBr 20 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670678 | acetaminophen 650 MG / dextromethorphan HBr 20 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2670679 | vasopressin (USP) 1 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2670680 | vasopressin (USP) 50 UNT in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2670680 | vasopressin (USP) 50 UNT in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670680 | vasopressin (USP) 50 UNT in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670680 | vasopressin (USP) 50 UNT in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670681 | vasopressin (USP) 1 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2670682 | vasopressin (USP) 1 UNT/ML [Vasostrict] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2670683 | Vasostrict 50 UNT in 50 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2670683 | Vasostrict 50 UNT in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670683 | Vasostrict 50 UNT in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2670683 | Vasostrict 50 UNT in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2670684 | vasopressin (USP) 1 UNT/ML Injection [Vasostrict] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2670684 | vasopressin (USP) 1 UNT/ML Injection [Vasostrict] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 267073 | Dimethoxyphenyl penicillin sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 267073 | Dimethoxyphenyl penicillin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 267073 | Dimethoxyphenyl penicillin sodium | Designated preferred name (PT) | NO | |
| RxCUI: 267073 | Dimethoxyphenyl penicillin sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 267073 | Dimethoxyphenyl penicillin sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 267073 | Dimethoxyphenyl penicillin sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 267073 | Dimethoxyphenyl penicillin sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671053 | pregabalin 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2671054 | pregabalin 50 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2671054 | pregabalin 50 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671054 | pregabalin 50 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2671055 | Bonqat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2671056 | pregabalin 50 MG/ML [Bonqat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2671057 | Bonqat Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2671058 | Bonqat Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2671059 | pregabalin Oral Solution [Bonqat] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2671060 | Bonqat 50 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2671060 | Bonqat 50 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671060 | Bonqat 50 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671060 | Bonqat 50 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2671061 | iptacopan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2671062 | iptacopan hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2671070 | iptacopan 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2671071 | iptacopan Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2671072 | iptacopan Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2671073 | iptacopan Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2671074 | iptacopan 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671074 | iptacopan 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671074 | iptacopan 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671075 | Fabhalta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2671076 | iptacopan 200 MG [Fabhalta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671077 | Fabhalta Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671078 | Fabhalta Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671079 | iptacopan Oral Capsule [Fabhalta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671080 | FABHALTA 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671080 | FABHALTA 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671080 | FABHALTA 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671080 | FABHALTA 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671082 | levomefolate calcium 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2671083 | cholecalciferol / levomefolate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2671084 | cholecalciferol / levomefolate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2671085 | cholecalciferol / levomefolate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2671086 | cholecalciferol / levomefolate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2671090 | cholecalciferol 125 MCG (5000 UNT) / levomefolate calcium 1000 MCG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671090 | cholecalciferol 125 MCG (5000 UNT) / levomefolate calcium 1000 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671090 | cholecalciferol 125 MCG (5000 UNT) / levomefolate calcium 1000 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671091 | Folixate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2671092 | cholecalciferol 0.125 MG / levomefolate calcium 1 MG [Folixate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671093 | Folixate Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671094 | Folixate Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671095 | cholecalciferol / levomefolate Oral Tablet [Folixate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671097 | Folixate 125 MCG (5000 UNT) / 1000 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671097 | Folixate 125 MCG (5000 UNT) / 1000 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671097 | Folixate 125 MCG (5000 UNT) / 1000 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671098 | adalimumab-aaty Prefilled Syringe 80 MG/0.8 ML and 40 MG/0.4 ML Starter Pack for Pediatric Crohn's Disease, Patient Weight 17 - 40 KG | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2671098 | adalimumab-aaty Prefilled Syringe 80 MG/0.8 ML and 40 MG/0.4 ML Starter Pack for Pediatric Crohn's Disease, Patient Weight 17 - 40 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671098 | adalimumab-aaty Prefilled Syringe 80 MG/0.8 ML and 40 MG/0.4 ML Starter Pack for Pediatric Crohn's Disease, Patient Weight 17 - 40 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671099 | Yuflyma Prefilled Syringe 80 MG/0.8 ML and 40 MG/0.4 ML Starter Pack for Pediatric Crohn's Disease, Patient Weight 17 - 40 KG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2671099 | Yuflyma Prefilled Syringe 80 MG/0.8 ML and 40 MG/0.4 ML Starter Pack for Pediatric Crohn's Disease, Patient Weight 17 - 40 KG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671099 | Yuflyma Prefilled Syringe 80 MG/0.8 ML and 40 MG/0.4 ML Starter Pack for Pediatric Crohn's Disease, Patient Weight 17 - 40 KG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671189 | dextromethorphan HBr 18 MG / guaiFENesin 396 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671189 | dextromethorphan HBr 18 MG / guaiFENesin 396 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671189 | dextromethorphan HBr 18 MG / guaiFENesin 396 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671189 | dextromethorphan HBr 18 MG / guaiFENesin 396 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671189 | dextromethorphan HBr 18 MG / guaiFENesin 396 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671190 | petrolatum 0.507 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2671191 | petrolatum 50.7 % / zinc oxide 40 % Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2671191 | petrolatum 50.7 % / zinc oxide 40 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671191 | petrolatum 50.7 % / zinc oxide 40 % Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2671191 | petrolatum 50.7 % / zinc oxide 40 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671192 | Hepzato | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2671193 | melphalan 50 MG [Hepzato] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671194 | Hepzato Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671195 | melphalan Injection [Hepzato] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671196 | HEPZATO 50 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671196 | HEPZATO 50 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671196 | HEPZATO 50 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671200 | potassium hydroxycitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2671201 | Silybum marianum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2671203 | phenobarbital sodium 130 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2671203 | phenobarbital sodium 130 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671204 | PHENobarbital sodium 130 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671204 | PHENobarbital sodium 130 MG in 1 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671204 | PHENobarbital sodium 130 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671204 | PHENobarbital sodium 130 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671204 | PHENobarbital sodium 130 MG in 1 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671205 | phenobarbital sodium 130 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2671205 | phenobarbital sodium 130 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2671206 | phenobarbital sodium 65 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2671206 | phenobarbital sodium 65 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671207 | PHENobarbital sodium 65 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671207 | PHENobarbital sodium 65 MG in 1 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671207 | PHENobarbital sodium 65 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671207 | PHENobarbital sodium 65 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671207 | PHENobarbital sodium 65 MG in 1 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671208 | phenobarbital sodium 65 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2671208 | phenobarbital sodium 65 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2671242 | poly(DL-lactic-co-glycolic acid), (75:25; 9500 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2671243 | tetramethylchromanol glucose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2671246 | Salycim | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2671247 | salicylic acid 60 MG/ML [Salycim] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671248 | Salycim Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671249 | salicylic acid Topical Cream [Salycim] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671250 | Salycim 6 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671250 | Salycim 6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671250 | Salycim 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671293 | 3,7-dimethyloct-6-en-3-ol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2671294 | hydrocortisone 6.67 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2671295 | hydrocortisone / tolnaftate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2671296 | hydrocortisone / tolnaftate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2671297 | hydrocortisone / tolnaftate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2671298 | hydrocortisone 0.667 % / tolnaftate 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671298 | hydrocortisone 0.667 % / tolnaftate 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671298 | hydrocortisone 0.667 % / tolnaftate 1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671300 | Tridergel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2671301 | benzalkonium chloride 0.001 MG/MG [Tridergel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671302 | Tridergel Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671303 | benzalkonium Topical Gel [Tridergel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671305 | TRIDERGEL 0.1 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671305 | TRIDERGEL 0.1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671305 | TRIDERGEL 0.1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671305 | TRIDERGEL 0.1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671358 | Lavandula angustifolia subsp. angustifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2671359 | 1-ethoxyundecane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 26714 | Hemorrhagic proteinase IV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26714 | Hemorrhagic proteinase IV | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26714 | Hemorrhagic proteinase IV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26714 | Hemorrhagic proteinase IV | Designated preferred name (PT) | NO | |
| RxCUI: 26714 | Hemorrhagic proteinase IV | Full form of descriptor (FN) | NO | |
| RxCUI: 2671447 | chlophedianol / dexchlorpheniramine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2671448 | chlophedianol / dexchlorpheniramine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2671449 | chlophedianol / dexchlorpheniramine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2671450 | chlophedianol / dexchlorpheniramine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2671454 | chlophedianol hydrochloride 12.5 MG / dexchlorpheniramine maleate 1 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671454 | chlophedianol hydrochloride 12.5 MG / dexchlorpheniramine maleate 1 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671454 | chlophedianol hydrochloride 12.5 MG / dexchlorpheniramine maleate 1 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671455 | methotrexate 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2671456 | methotrexate 2 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671456 | methotrexate 2 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671456 | methotrexate 2 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671457 | Jylamvo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2671458 | methotrexate 2 MG/ML [Jylamvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671459 | Jylamvo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671460 | Jylamvo Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671461 | methotrexate Oral Solution [Jylamvo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671462 | Jylamvo 2 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671462 | Jylamvo 2 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671462 | Jylamvo 2 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671570 | sodium citrate 460 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2671571 | sodium citrate Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2671572 | sodium citrate Powder for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2671573 | sodium citrate 460 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2671573 | sodium citrate 460 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2671573 | sodium citrate 460 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671574 | Emetrol Powder | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2671575 | sodium citrate 460 MG [Emetrol Powder] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2671576 | Emetrol Powder Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2671577 | Emetrol Powder Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2671578 | sodium citrate Powder for Oral Solution [Emetrol Powder] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2671579 | Emetrol Powder 460 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2671579 | Emetrol Powder 460 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671579 | Emetrol Powder 460 MG Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2671580 | benzalkonium chloride 0.09 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2671580 | benzalkonium chloride 0.09 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671580 | benzalkonium chloride 0.09 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2671582 | tert-butylbenzoic acid (mixed isomers) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2671583 | cysteine Injectable Solution [Elcys] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671585 | ELCYS 50 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671585 | ELCYS 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671585 | ELCYS 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671586 | Adthyza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2671587 | thyroid (USP) 15 MG [Adthyza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671588 | Adthyza Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671589 | Adthyza Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671590 | thyroid (USP) Oral Tablet [Adthyza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671591 | ADTHYZA 15 MG (1/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671591 | ADTHYZA 15 MG (1/4 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671591 | ADTHYZA 15 MG (1/4 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671593 | thyroid (USP) 30 MG [Adthyza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671594 | ADTHYZA 30 MG (1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671594 | ADTHYZA 30 MG (1/2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671594 | ADTHYZA 30 MG (1/2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671595 | thyroid (USP) 60 MG [Adthyza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671596 | ADTHYZA 60 MG (1 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671596 | ADTHYZA 60 MG (1 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671596 | ADTHYZA 60 MG (1 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671597 | thyroid (USP) 90 MG [Adthyza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671598 | ADTHYZA 90 MG (1 1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671598 | ADTHYZA 90 MG (1 1/2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671598 | ADTHYZA 90 MG (1 1/2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671599 | thyroid (USP) 120 MG [Adthyza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671600 | ADTHYZA 120 MG (2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671600 | ADTHYZA 120 MG (2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671600 | ADTHYZA 120 MG (2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671625 | collagen alpha-1(II) chain (human) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2671667 | exagamglogene autotemcel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2671668 | exagamglogene autotemcel 13000000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2671669 | exagamglogene autotemcel Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2671670 | exagamglogene autotemcel Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2671671 | exagamglogene autotemcel 13,000,000 CELLS/ML in 1.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671671 | exagamglogene autotemcel 13,000,000 CELLS/ML in 1.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671671 | exagamglogene autotemcel 13,000,000 CELLS/ML in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671672 | exagamglogene autotemcel 13000000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2671673 | Casgevy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2671674 | exagamglogene autotemcel 13000000 CELLS/ML [Casgevy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671675 | Casgevy Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671676 | exagamglogene autotemcel Injection [Casgevy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671677 | casgevy 13,000,000 CELLS/mL in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671677 | casgevy 13,000,000 CELLS/mL in 1.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671677 | casgevy 13,000,000 CELLS/mL in 1.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671677 | casgevy 13,000,000 CELLS/mL in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671678 | exagamglogene autotemcel 13000000 CELLS/ML Injection [Casgevy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671678 | exagamglogene autotemcel 13000000 CELLS/ML Injection [Casgevy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2671679 | ePHEDrine hydrochloride 47 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671679 | ePHEDrine hydrochloride 47 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671679 | ePHEDrine hydrochloride 47 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671679 | ePHEDrine hydrochloride 47 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671679 | ePHEDrine hydrochloride 47 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671680 | REZIPRES 47 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671680 | REZIPRES 47 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2671680 | REZIPRES 47 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671680 | REZIPRES 47 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671680 | REZIPRES 47 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671681 | roflumilast Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2671682 | roflumilast 0.3 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671682 | roflumilast 0.3 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671682 | roflumilast 0.3 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671683 | roflumilast Topical Foam [Zoryve] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671684 | ZORYVE 0.3 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671684 | ZORYVE 0.3 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671684 | ZORYVE 0.3 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671684 | ZORYVE 0.3 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671685 | penicillin G benzathine 1200000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2671687 | penicillin G benzathine 1,200,000 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671687 | penicillin G benzathine 1,200,000 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671687 | penicillin G benzathine 1,200,000 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671688 | Extencilline | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2671689 | penicillin G benzathine 1200000 UNT [Extencilline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671690 | Extencilline Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671691 | penicillin G Injection [Extencilline] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671693 | EXTENCILLINE 1,200,000 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671693 | EXTENCILLINE 1,200,000 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671693 | EXTENCILLINE 1,200,000 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671693 | EXTENCILLINE 1,200,000 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671694 | penicillin G benzathine 2400000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2671695 | penicillin G benzathine 2,400,000 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671695 | penicillin G benzathine 2,400,000 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671695 | penicillin G benzathine 2,400,000 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671696 | penicillin G benzathine 2400000 UNT [Extencilline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671697 | EXTENCILLINE 2,400,000 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671697 | EXTENCILLINE 2,400,000 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671697 | EXTENCILLINE 2,400,000 UNT Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671697 | EXTENCILLINE 2,400,000 UNT Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671698 | diphenhydramine hydrochloride 16.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2671698 | diphenhydramine hydrochloride 16.7 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2671699 | diphenhydrAMINE HCl 50 MG in 3 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2671699 | diphenhydrAMINE HCl 50 MG in 3 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671699 | diphenhydrAMINE HCl 50 MG in 3 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2671699 | diphenhydrAMINE HCl 50 MG in 3 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2671699 | diphenhydrAMINE HCl 50 MG in 3 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 267171 | Fenoprofen calcium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 267171 | Fenoprofen calcium | Designated preferred name (PT) | YES | |
| RxCUI: 267171 | Fenoprofen calcium | Full form of descriptor (FN) | YES | |
| RxCUI: 2671785 | Myrica esculenta fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2671939 | eplontersen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2671940 | eplontersen sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2671941 | eplontersen 56.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2671942 | eplontersen Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2671943 | eplontersen Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2671944 | eplontersen 45 MG in 0.8 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2671944 | eplontersen 45 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671944 | eplontersen 45 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671944 | eplontersen 45 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671945 | eplontersen 56.3 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2671946 | Wainua | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2671947 | eplontersen 56.3 MG/ML [Wainua] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2671948 | Wainua Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2671949 | eplontersen Auto-Injector [Wainua] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2671950 | WAINUA 45 MG in 0.8 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2671950 | WAINUA 45 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671950 | WAINUA 45 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2671950 | WAINUA 45 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2671951 | eplontersen 56.3 MG/ML Auto-Injector [Wainua] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2671951 | eplontersen 56.3 MG/ML Auto-Injector [Wainua] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671955 | methyl salicylate 6.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2671956 | capsaicin 0.012 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2671957 | capsaicin 0.0012 % / methyl salicylate 0.61 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2671957 | capsaicin 0.0012 % / methyl salicylate 0.61 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2671957 | capsaicin 0.0012 % / methyl salicylate 0.61 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2671958 | lovotibeglogene autotemcel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2672 | Codeine phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2672 | Codeine phosphate | Designated preferred name (PT) | YES | |
| RxCUI: 2672 | Codeine phosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 2672085 | travoprost 0.075 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672086 | travoprost Drug Implant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2672087 | travoprost Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2672088 | travoprost 75 MCG Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672088 | travoprost 75 MCG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672088 | travoprost 75 MCG Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672089 | iDose | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2672090 | travoprost 0.075 MG [iDose] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2672091 | iDose Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2672092 | travoprost Drug Implant [iDose] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2672093 | iDose TR 75 MCG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672093 | iDose TR 75 MCG Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672093 | iDose TR 75 MCG Drug Implant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672094 | immune globulin intravenous (human) - stwk | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2672095 | immune globulin intravenous (human) - stwk 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672098 | immune globulin intravenous (human) - stwk 10 % in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672098 | immune globulin intravenous (human) - stwk 10 % in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672098 | immune globulin intravenous (human) - stwk 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672098 | immune globulin intravenous (human) - stwk 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672098 | immune globulin intravenous (human) - stwk 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672099 | immune globulin intravenous (human) - stwk 100 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672100 | Alyglo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2672101 | immune globulin intravenous (human) - stwk 100 MG/ML [Alyglo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2672102 | Alyglo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2672103 | immunoglobulin G Injection [Alyglo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2672105 | Alyglo 10 % in 50 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672105 | Alyglo 10 % in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672105 | Alyglo 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672105 | Alyglo 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672105 | Alyglo 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672106 | immune globulin intravenous (human) - stwk 100 MG/ML Injection [Alyglo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672106 | immune globulin intravenous (human) - stwk 100 MG/ML Injection [Alyglo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2672107 | immune globulin intravenous (human) - stwk 10 % in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672107 | immune globulin intravenous (human) - stwk 10 % in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672107 | immune globulin intravenous (human) - stwk 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672107 | immune globulin intravenous (human) - stwk 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672107 | immune globulin intravenous (human) - stwk 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672108 | Alyglo 10 % in 100 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672108 | Alyglo 10 % in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672108 | Alyglo 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672108 | Alyglo 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672108 | Alyglo 10 % in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672109 | immune globulin intravenous (human) - stwk 10 % in 200 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672109 | immune globulin intravenous (human) - stwk 10 % in 200 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672109 | immune globulin intravenous (human) - stwk 10 % in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672109 | immune globulin intravenous (human) - stwk 10 % in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672109 | immune globulin intravenous (human) - stwk 10 % in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672110 | Alyglo 10 % in 200 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672110 | Alyglo 10 % in 200 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672110 | Alyglo 10 % in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672110 | Alyglo 10 % in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672110 | Alyglo 10 % in 200 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672253 | gepirone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2672254 | gepirone hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2672261 | Pongamia pinnata fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2672325 | bosutinib Oral Capsule [Bosulif] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2672326 | Bosulif 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672326 | Bosulif 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672326 | Bosulif 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672327 | bosutinib 50 MG [Bosulif] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2672328 | Bosulif 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672328 | Bosulif 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672328 | Bosulif 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672329 | methyl salicylate 0.002 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2672330 | camphor 10.8 % / eucalyptus oil 7 % / menthol 11 % / methyl salicylate 0.2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672330 | camphor 10.8 % / eucalyptus oil 7 % / menthol 11 % / methyl salicylate 0.2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672330 | camphor 10.8 % / eucalyptus oil 7 % / menthol 11 % / methyl salicylate 0.2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672331 | Eucalyptus oil 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2672332 | methyl salicylate 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2672333 | camphor 10.8 % / eucalyptus oil 7 % / menthol 11 % / methyl salicylate 0.2 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672333 | camphor 10.8 % / eucalyptus oil 7 % / menthol 11 % / methyl salicylate 0.2 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672333 | camphor 10.8 % / eucalyptus oil 7 % / menthol 11 % / methyl salicylate 0.2 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672334 | camphor 11 % / menthol 16 % / methyl salicylate 30 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672334 | camphor 11 % / menthol 16 % / methyl salicylate 30 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672334 | camphor 11 % / menthol 16 % / methyl salicylate 30 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672335 | camphor 22 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2672336 | camphor 2.2 % / menthol 14 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672336 | camphor 2.2 % / menthol 14 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672336 | camphor 2.2 % / menthol 14 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672340 | benzophenone-4-isothiocyanate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2672341 | tazarotene Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2672342 | tazarotene Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2672343 | tazarotene 0.05 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672343 | tazarotene 0.05 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672343 | tazarotene 0.05 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672344 | azelaic acid 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2672345 | azelate / tranexamic acid | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2672346 | azelate / tranexamic acid Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2672347 | azelate / tranexamic acid Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2672350 | azelaic acid 5 % / tranexamic acid 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672350 | azelaic acid 5 % / tranexamic acid 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672350 | azelaic acid 5 % / tranexamic acid 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672351 | D&C red no. 33 free acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2672352 | lidocaine / phenylephrine Rectal Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2672354 | lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672354 | lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672354 | lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672355 | salicylic acid / zinc pyrithione Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2672356 | salicylic acid / zinc pyrithione Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2672357 | salicylic acid 1.5 % / zinc pyrithione 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672357 | salicylic acid 1.5 % / zinc pyrithione 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672357 | salicylic acid 1.5 % / zinc pyrithione 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672358 | salicylic acid / selenium sulfide / zinc pyrithione | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2672359 | salicylic acid / selenium sulfide / zinc pyrithione Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2672360 | salicylic acid / selenium sulfide / zinc pyrithione Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2672361 | salicylic acid 1 % / selenium sulfide 1 % / zinc pyrithione 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672361 | salicylic acid 1 % / selenium sulfide 1 % / zinc pyrithione 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672361 | salicylic acid 1 % / selenium sulfide 1 % / zinc pyrithione 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672362 | Salyntra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2672363 | salicylic acid 0.06 MG/MG [Salyntra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2672364 | Salyntra Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2672366 | salicylic acid Topical Gel [Salyntra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2672367 | Salyntra 6 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672367 | Salyntra 6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672367 | Salyntra 6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672368 | gepirone 18.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672369 | gepirone Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2672370 | gepirone Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2672371 | gepirone Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2672372 | gepirone 18.2 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672372 | gepirone 18.2 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672372 | gepirone 18.2 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672373 | gepirone 18.2 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672373 | gepirone 18.2 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672373 | gepirone 18.2 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672374 | Exxua | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2672375 | gepirone 18.2 MG [Exxua] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2672376 | Exxua Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2672377 | Exxua Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2672378 | gepirone Extended Release Oral Tablet [Exxua] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2672379 | EXXUA 18.2 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672379 | EXXUA 18.2 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672379 | EXXUA 18.2 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672379 | EXXUA 18.2 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672380 | EXXUA 18.2 MG (equivalent to 20 MG gepirone hydrochloride) Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672380 | EXXUA 18.2 MG (equivalent to 20 MG gepirone hydrochloride) Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672380 | EXXUA 18.2 MG (equivalent to 20 MG gepirone hydrochloride) Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2672381 | gepirone 36.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672382 | gepirone 36.3 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672382 | gepirone 36.3 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672382 | gepirone 36.3 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672383 | gepirone 36.3 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672383 | gepirone 36.3 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672383 | gepirone 36.3 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672384 | gepirone 36.3 MG [Exxua] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2672385 | EXXUA 36.3 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672385 | EXXUA 36.3 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672385 | EXXUA 36.3 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672385 | EXXUA 36.3 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672386 | EXXUA 36.3 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672386 | EXXUA 36.3 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672386 | EXXUA 36.3 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2672387 | gepirone 54.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672388 | gepirone 54.5 MG 24 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672388 | gepirone 54.5 MG 24 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672388 | gepirone 54.5 MG 24 HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672389 | gepirone 54.5 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672389 | gepirone 54.5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672390 | gepirone 54.5 MG [Exxua] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2672391 | EXXUA 54.5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672391 | EXXUA 54.5 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672391 | EXXUA 54.5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672391 | EXXUA 54.5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672392 | EXXUA 54.5 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672392 | EXXUA 54.5 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672392 | EXXUA 54.5 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2672393 | gepirone 72.6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672394 | gepirone 72.6 MG 24 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672394 | gepirone 72.6 MG 24 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672394 | gepirone 72.6 MG 24 HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672395 | gepirone 72.6 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672395 | gepirone 72.6 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672395 | gepirone 72.6 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672396 | gepirone 72.6 MG [Exxua] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2672397 | EXXUA 72.6 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672397 | EXXUA 72.6 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672397 | EXXUA 72.6 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672397 | EXXUA 72.6 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672398 | EXXUA 72.6 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672398 | EXXUA 72.6 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672398 | EXXUA 72.6 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2672488 | 2-(perfluorohexyl)ethanethiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2672489 | zilucoplan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2672490 | carboxymethylcellulose sodium 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672491 | carboxymethylcellulose sodium 0.6 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672491 | carboxymethylcellulose sodium 0.6 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672491 | carboxymethylcellulose sodium 0.6 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672491 | carboxymethylcellulose sodium 0.6 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672492 | zilucoplan sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2672493 | zilucoplan 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672494 | zilucoplan Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2672495 | zilucoplan Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2672496 | zilucoplan 16.6 MG in 0.416 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672496 | zilucoplan 16.6 MG in 0.416 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672496 | zilucoplan 16.6 MG in 0.416 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672497 | zilucoplan 40 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672497 | zilucoplan 40 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672497 | zilucoplan 40 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672498 | Zilbrysq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2672499 | zilucoplan 40 MG/ML [Zilbrysq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 26725 | Heparan N-sulfatase | Designated preferred name (PT) | NO | |
| RxCUI: 26725 | Heparan N-sulfatase | Full form of descriptor (FN) | NO | |
| RxCUI: 2672500 | Zilbrysq Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2672501 | zilucoplan Prefilled Syringe [Zilbrysq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2672502 | ZILBRYSQ 16.6 MG in 0.416 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672502 | ZILBRYSQ 16.6 MG in 0.416 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672502 | ZILBRYSQ 16.6 MG in 0.416 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672503 | ZILBRYSQ 40 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672503 | ZILBRYSQ 40 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672503 | ZILBRYSQ 40 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2672504 | zilucoplan 23 MG in 0.574 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672504 | zilucoplan 23 MG in 0.574 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672504 | zilucoplan 23 MG in 0.574 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672505 | ZILBRYSQ 23 MG in 0.574 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672505 | ZILBRYSQ 23 MG in 0.574 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672505 | ZILBRYSQ 23 MG in 0.574 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672506 | zilucoplan 32.4 MG in 0.81 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672506 | zilucoplan 32.4 MG in 0.81 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672506 | zilucoplan 32.4 MG in 0.81 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672507 | ZILBRYSQ 32.4 MG in 0.81 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672507 | ZILBRYSQ 32.4 MG in 0.81 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672507 | ZILBRYSQ 32.4 MG in 0.81 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 267251 | dextromethorphan hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2672539 | Oenocarpus bataua seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 267257 | Sodium dicloxacillin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 267257 | Sodium dicloxacillin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 267257 | Sodium dicloxacillin | Designated preferred name (PT) | YES | |
| RxCUI: 267257 | Sodium dicloxacillin | Full form of descriptor (FN) | YES | |
| RxCUI: 267257 | Sodium dicloxacillin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 267257 | Sodium dicloxacillin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672688 | lovotibeglogene autotemcel 20000000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672689 | lovotibeglogene autotemcel Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2672690 | lovotibeglogene autotemcel Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2672691 | lovotibeglogene autotemcel 20,000,000 CELLS/ML in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672691 | lovotibeglogene autotemcel 20,000,000 CELLS/ML in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672691 | lovotibeglogene autotemcel 20,000,000 CELLS/ML in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672692 | lovotibeglogene autotemcel 20000000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672693 | Lyfgenia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2672694 | lovotibeglogene autotemcel 20000000 CELLS/ML [Lyfgenia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2672695 | Lyfgenia Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2672696 | lovotibeglogene autotemcel Injection [Lyfgenia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2672697 | lyfgenia 20,000,000 CELLS/ML in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672697 | lyfgenia 20,000,000 CELLS/ML in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672697 | lyfgenia 20,000,000 CELLS/ML in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672698 | lovotibeglogene autotemcel 20000000 CELLS/ML Injection [Lyfgenia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2672698 | lovotibeglogene autotemcel 20000000 CELLS/ML Injection [Lyfgenia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672725 | camphor 5 % / menthol 6 % / methyl salicylate 10 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672725 | camphor 5 % / menthol 6 % / methyl salicylate 10 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672725 | camphor 5 % / menthol 6 % / methyl salicylate 10 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672726 | camphor 50 MG/ML / menthol 60 MG/ML / methyl salicylate 100 MG/ML [Satohap] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2672727 | SATOHAP 5 % / 6 % / 10 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2672727 | SATOHAP 5 % / 6 % / 10 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672727 | SATOHAP 5 % / 6 % / 10 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672730 | enalaprilat dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 26728 | Heparin eliminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26728 | Heparin eliminase | Designated preferred name (PT) | NO | |
| RxCUI: 26728 | Heparin eliminase | Full form of descriptor (FN) | NO | |
| RxCUI: 26728 | Heparin eliminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672825 | menthol 0.0766 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2672826 | menthol 7.66 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672826 | menthol 7.66 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672826 | menthol 7.66 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2672916 | chlophedianol hydrochloride 0.833 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672917 | chlophedianol HCl 25 MG / pyrilamine maleate 50 MG in 30 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672917 | chlophedianol HCl 25 MG / pyrilamine maleate 50 MG in 30 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672917 | chlophedianol HCl 25 MG / pyrilamine maleate 50 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672917 | chlophedianol HCl 25 MG / pyrilamine maleate 50 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672921 | ferrous bisglycinate 36.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2672922 | ferrous bisglycinate 36.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672922 | ferrous bisglycinate 36.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672923 | Eth estra-Levonorgest 0.02-0.1 MG (21) Oral Tablet / ferrous bisglycinate 36.5 MG (7) Oral Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2672923 | Eth estra-Levonorgest 0.02-0.1 MG (21) Oral Tablet / ferrous bisglycinate 36.5 MG (7) Oral Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672926 | nalmefene 100 MCG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2672926 | nalmefene 100 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672926 | nalmefene 100 MCG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672927 | nalmefene 0.1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672950 | Rizafilm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2672951 | rizatriptan 10 MG [Rizafilm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2672952 | Rizafilm Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2672953 | Rizafilm Oral Film Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2672954 | rizatriptan Oral Film [Rizafilm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2672955 | RizaFilm 10 MG Oral Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672955 | RizaFilm 10 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2672955 | RizaFilm 10 MG Oral Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2672955 | RizaFilm 10 MG Oral Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2672956 | menthol 0.155 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2672957 | camphor 4 % / menthol 15.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2672957 | camphor 4 % / menthol 15.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2672957 | camphor 4 % / menthol 15.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673087 | carboprost Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2673088 | carboprost tromethamine 250 MCG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2673088 | carboprost tromethamine 250 MCG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673088 | carboprost tromethamine 250 MCG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673089 | carboprost 0.25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2673090 | naloxone hydrochloride 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2673091 | naloxone HCl 3 MG per 0.1 ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673091 | naloxone HCl 3 MG per 0.1 ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673091 | naloxone HCl 3 MG per 0.1 ML Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2673092 | Apur | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2673093 | thyroid (USP) 90 MG [Apur] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2673094 | Apur Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2673095 | Apur Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2673096 | thyroid (USP) Oral Tablet [Apur] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2673097 | APurThyroid 90 MG (1 1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673097 | APurThyroid 90 MG (1 1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673097 | APurThyroid 90 MG (1 1/2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673097 | APurThyroid 90 MG (1 1/2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673098 | thyroid (USP) 60 MG [Apur] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2673099 | APur Thyroid 60 MG (1 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673099 | APur Thyroid 60 MG (1 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673099 | APur Thyroid 60 MG (1 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673099 | APur Thyroid 60 MG (1 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673100 | thyroid (USP) 30 MG [Apur] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2673101 | APur Thyroid 30 MG (1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673101 | APur Thyroid 30 MG (1/2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673101 | APur Thyroid 30 MG (1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673101 | APur Thyroid 30 MG (1/2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673102 | thyroid (USP) 15 MG [Apur] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2673103 | APur Thyroid 15 MG (1/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673103 | APur Thyroid 15 MG (1/4 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673103 | APur Thyroid 15 MG (1/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673103 | APur Thyroid 15 MG (1/4 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673104 | thyroid (USP) 120 MG [Apur] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2673105 | APur Thyroid 120 MG (2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673105 | APur Thyroid 120 MG (2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673105 | APur Thyroid 120 MG (2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673105 | APur Thyroid 120 MG (2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673183 | Belprofen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2673184 | carprofen 100 MG [Belprofen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2673185 | Belprofen Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2673186 | Belprofen Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2673187 | carprofen Oral Tablet [Belprofen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2673188 | Belprofen 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673188 | Belprofen 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673188 | Belprofen 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673189 | carprofen 25 MG [Belprofen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2673190 | Belprofen 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673190 | Belprofen 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673190 | Belprofen 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673191 | carprofen 75 MG [Belprofen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2673192 | Belprofen 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673192 | Belprofen 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673192 | Belprofen 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673193 | glyceryl 1,2-dioleate, (S)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2673194 | Melaleuca viridiflora flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2673195 | eflornithine 192 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2673196 | eflornithine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2673197 | eflornithine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2673198 | eflornithine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2673199 | eflornithine 192 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673199 | eflornithine 192 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673199 | eflornithine 192 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2673200 | Iwilfin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2673201 | eflornithine 192 MG [Iwilfin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2673202 | Iwilfin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2673203 | Iwilfin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2673204 | eflornithine Oral Tablet [Iwilfin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2673205 | iwilfin 192 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673205 | iwilfin 192 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673205 | iwilfin 192 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673205 | iwilfin 192 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673206 | camphor 3 % / menthol 3 % / methyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673206 | camphor 3 % / menthol 3 % / methyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673206 | camphor 3 % / menthol 3 % / methyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2673234 | neostigmine Prefilled Syringe [Bloxiverz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2673236 | Bloxiverz 5 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673236 | Bloxiverz 5 MG in 5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673236 | Bloxiverz 5 MG in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673236 | Bloxiverz 5 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673237 | neostigmine methylsulfate 1 MG/ML Prefilled Syringe [Bloxiverz] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673237 | neostigmine methylsulfate 1 MG/ML Prefilled Syringe [Bloxiverz] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673238 | chikungunya virus antigen, live attenuated LR2006 OPY1 strain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2673239 | chikungunya virus antigen, live attenuated LR2006 OPY1 strain 2000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2673240 | chikungunya virus antigen, live attenuated LR2006 OPY1 strain Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2673241 | chikungunya virus antigen, live attenuated LR2006 OPY1 strain Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2673242 | chikungunya virus vaccine live 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2673242 | chikungunya virus vaccine live 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673242 | chikungunya virus vaccine live 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673243 | Ixchiq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2673244 | chikungunya virus antigen, live attenuated LR2006 OPY1 strain 2000 UNT [Ixchiq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2673245 | Ixchiq Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2673246 | chikungunya virus antigen, live attenuated LR2006 OPY1 strain Injection [Ixchiq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2673247 | IXCHIQ vaccine live 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673247 | IXCHIQ vaccine live 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673247 | IXCHIQ vaccine live 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673247 | IXCHIQ vaccine live 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673303 | Typhonium giganteum stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2673304 | lidocaine 4 % / phenylephrine HCl 0.25 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2673304 | lidocaine 4 % / phenylephrine HCl 0.25 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673304 | lidocaine 4 % / phenylephrine HCl 0.25 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 267342 | Spectinomycin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 267342 | Spectinomycin hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 267342 | Spectinomycin hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2673424 | trilostane 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2673425 | trilostane 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673425 | trilostane 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2673426 | trilostane 20 MG [Vetoryl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2673427 | VETORYL 20 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673427 | VETORYL 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673427 | VETORYL 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673428 | levOCARNitine 4 GM in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2673428 | levOCARNitine 4 GM in 20 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2673428 | levOCARNitine 4 GM in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673428 | levOCARNitine 4 GM in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673428 | levOCARNitine 4 GM in 20 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2673463 | dexlansoprazole sesquihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2673464 | hydracrylic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2673512 | metahomomenthol, (+/-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2673514 | Testo-200 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2673515 | testosterone cypionate 200 MG/ML [Testo-200] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2673516 | Testo-200 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2673517 | testosterone Injectable Solution [Testo-200] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2673519 | TESTO-200 200 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673519 | TESTO-200 200 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673519 | TESTO-200 200 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673585 | vasicinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2673586 | Euphorbia neriifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2673587 | oxymethurea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2673588 | acetic acid 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2673589 | benzoic acid 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2673590 | acetic acid / benzoate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2673591 | acetic acid / benzoate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2673592 | acetic acid / benzoate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2673595 | acetic acid 25 % / benzoic acid 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673595 | acetic acid 25 % / benzoic acid 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673595 | acetic acid 25 % / benzoic acid 25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2673598 | pegfilgrastim-cbqv 6 MG in 0.6 ML On-body Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2673598 | pegfilgrastim-cbqv 6 MG in 0.6 ML On-body Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673598 | pegfilgrastim-cbqv 6 MG in 0.6 ML On-body Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673599 | pegfilgrastim-cbqv 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 267360 | Amoxicillin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 267360 | Amoxicillin sodium | Designated preferred name (PT) | YES | |
| RxCUI: 267360 | Amoxicillin sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 2673600 | pegfilgrastim Injection [Udenyca] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2673602 | UDENYCA 6 MG in 0.6 ML Onbody Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673602 | UDENYCA 6 MG in 0.6 ML Onbody Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673602 | UDENYCA 6 MG in 0.6 ML Onbody Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673602 | UDENYCA 6 MG in 0.6 ML Onbody Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673603 | pegfilgrastim-cbqv 10 MG/ML Injection [Udenyca] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673603 | pegfilgrastim-cbqv 10 MG/ML Injection [Udenyca] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 267366 | Sodium ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 267366 | Sodium ascorbate | Designated preferred name (PT) | YES | |
| RxCUI: 267366 | Sodium ascorbate | Full form of descriptor (FN) | YES | |
| RxCUI: 2673690 | ibuprofen Oral Capsule [Proprinal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2673691 | Proprinal 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673691 | Proprinal 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673691 | Proprinal 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673692 | tetracaine 0.019 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2673693 | tetracaine 1.9 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2673693 | tetracaine 1.9 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673693 | tetracaine 1.9 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26737 | Heparitin sulfotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 26737 | Heparitin sulfotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 26737 | Heparitin sulfotransferase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673753 | Opuntia tuna stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2673755 | pimeclone hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2673756 | pimeclone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2673760 | omalizumab 150 MG per 1 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2673760 | omalizumab 150 MG per 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673760 | omalizumab 150 MG per 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673761 | Xolair 150 MG in 1 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673761 | Xolair 150 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673761 | Xolair 150 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673762 | omalizumab 75 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2673762 | omalizumab 75 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673762 | omalizumab 75 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673763 | Xolair 75 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673763 | Xolair 75 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673763 | Xolair 75 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673797 | camphor 4.8 % / menthol 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2673797 | camphor 4.8 % / menthol 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673797 | camphor 4.8 % / menthol 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673842 | Selarid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2673843 | selamectin 120 MG/ML [Selarid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2673844 | Selarid Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2673845 | selamectin Topical Solution [Selarid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2673846 | Selarid 120 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673846 | Selarid 120 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673846 | Selarid 120 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673847 | selamectin 60 MG/ML [Selarid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2673848 | Selarid 60 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673848 | Selarid 60 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673848 | Selarid 60 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673850 | Ovamed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2673851 | altrenogest 2.2 MG/ML [Ovamed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2673852 | Ovamed Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2673853 | Ovamed Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2673854 | altrenogest Oral Solution [Ovamed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2673855 | OvaMed 0.22 % Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673855 | OvaMed 0.22 % Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673855 | OvaMed 0.22 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673855 | OvaMed 0.22 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673859 | Kiprofen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2673860 | ketoprofen 25 MG [Kiprofen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2673861 | Kiprofen Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2673862 | Kiprofen Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2673863 | ketoprofen Oral Capsule [Kiprofen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2673864 | KIPROFEN 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673864 | KIPROFEN 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673864 | KIPROFEN 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673865 | 1-chloronaphthalene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2673866 | isotachysterol 3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2673867 | mineral oil 140 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2673868 | petrolatum 749 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2673869 | mineral oil / petrolatum / phenylephrine Rectal Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2673871 | mineral oil 14 % / petrolatum 74.9 % / phenylephrine HCl 0.25 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673871 | mineral oil 14 % / petrolatum 74.9 % / phenylephrine HCl 0.25 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673871 | mineral oil 14 % / petrolatum 74.9 % / phenylephrine HCl 0.25 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2673872 | acetaminophen / ibuprofen Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2673873 | acetaminophen / ibuprofen Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2673874 | acetaminophen 1000 MG / ibuprofen 300 MG in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2673874 | acetaminophen 1000 MG / ibuprofen 300 MG in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673874 | acetaminophen 1000 MG / ibuprofen 300 MG in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673874 | acetaminophen 1000 MG / ibuprofen 300 MG in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673875 | acetaminophen 10 MG/ML / ibuprofen 3 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2673875 | acetaminophen 10 MG/ML / ibuprofen 3 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2673875 | acetaminophen 10 MG/ML / ibuprofen 3 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673876 | Combogesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2673877 | acetaminophen 10 MG/ML / ibuprofen 3 MG/ML [Combogesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2673878 | Combogesic Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2673879 | acetaminophen / ibuprofen Injection [Combogesic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2673880 | combogesic IV 1000 MG / 300 MG in 100 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2673880 | combogesic IV 1000 MG / 300 MG in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673880 | combogesic IV 1000 MG / 300 MG in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2673880 | combogesic IV 1000 MG / 300 MG in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2673881 | acetaminophen 10 MG/ML / ibuprofen 3 MG/ML Injection [Combogesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2673881 | acetaminophen 10 MG/ML / ibuprofen 3 MG/ML Injection [Combogesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673882 | Calcium carbonate and sodium alginate and sodium bicarbonate only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673882 | Calcium carbonate and sodium alginate and sodium bicarbonate only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673883 | Ceftobiprole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673883 | Ceftobiprole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673884 | Ceftobiprole only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673884 | Ceftobiprole only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673885 | Chlorhexidine and phenol only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673885 | Chlorhexidine and phenol only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673886 | Chlortalidone and olmesartan only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673886 | Chlortalidone and olmesartan only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673886 | Chlortalidone and olmesartan only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673887 | Chlortalidone and olmesartan only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673887 | Chlortalidone and olmesartan only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673887 | Chlortalidone and olmesartan only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673888 | Gimeracil and oteracil and tegafur only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673888 | Gimeracil and oteracil and tegafur only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673889 | Gimeracil and oteracil and tegafur only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673889 | Gimeracil and oteracil and tegafur only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673890 | Cilnidipine and olmesartan only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673890 | Cilnidipine and olmesartan only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673891 | Cilnidipine and olmesartan only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673891 | Cilnidipine and olmesartan only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673892 | Hepatitis B high dose recombinant surface antigen vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673892 | Hepatitis B high dose recombinant surface antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673892 | Hepatitis B high dose recombinant surface antigen vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673893 | Hepatitis B recombinant adsorbed surface antigen vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673893 | Hepatitis B recombinant adsorbed surface antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673893 | Hepatitis B recombinant adsorbed surface antigen vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673894 | Cytarabine and daunorubicin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673894 | Cytarabine and daunorubicin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673895 | Live attenuated rubella vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673895 | Live attenuated rubella vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673895 | Live attenuated rubella vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673896 | Live attenuated Zaire ebolavirus antigen only vaccine product | Designated preferred name (PT) | NO | |
| RxCUI: 2673896 | Live attenuated Zaire ebolavirus antigen only vaccine product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673897 | Product containing only taurolidine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2673897 | Product containing only taurolidine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2673898 | Product containing only taurolidine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2673898 | Product containing only taurolidine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2673899 | Pediatric vaccine product containing only Tick-borne encephalitis virus antigen (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2673899 | Pediatric vaccine product containing only Tick-borne encephalitis virus antigen (medicinal product) | British preferred term (PTGB) | NO | |
| RxCUI: 2673899 | Pediatric vaccine product containing only Tick-borne encephalitis virus antigen (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2673900 | Cytarabine and daunorubicin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673900 | Cytarabine and daunorubicin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673901 | Delafloxacin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673901 | Delafloxacin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673902 | Dexamethasone and levofloxacin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673902 | Dexamethasone and levofloxacin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673903 | Dexamethasone and levofloxacin only product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673903 | Dexamethasone and levofloxacin only product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673904 | Product containing only roxadustat (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2673904 | Product containing only roxadustat (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2673905 | Product containing only roxadustat in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2673905 | Product containing only roxadustat in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2673906 | Diethylamine salicylate only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673906 | Diethylamine salicylate only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673907 | Diethylamine salicylate only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673907 | Diethylamine salicylate only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673908 | Empagliflozin and metformin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673908 | Empagliflozin and metformin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673909 | Enterovirus A71 vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673909 | Enterovirus A71 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673909 | Enterovirus A71 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673909 | Enterovirus A71 vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673910 | Mitomycin only product in intravesical dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673910 | Mitomycin only product in intravesical dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673911 | Modified Vaccinia virus Ankara antigen only vaccine product | Designated preferred name (PT) | NO | |
| RxCUI: 2673911 | Modified Vaccinia virus Ankara antigen only vaccine product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673912 | Pneumococcal 13-valent conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673912 | Pneumococcal 13-valent conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673912 | Pneumococcal 13-valent conjugate vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673912 | Pneumococcal 13-valent conjugate vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673913 | Ezetimibe and rosuvastatin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673913 | Ezetimibe and rosuvastatin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673914 | Ezetimibe and rosuvastatin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673914 | Ezetimibe and rosuvastatin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673915 | Nimorazole only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673915 | Nimorazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673916 | RSV (respiratory syncytial virus) vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673916 | RSV (respiratory syncytial virus) vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673916 | RSV (respiratory syncytial virus) vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673917 | Filgotinib only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673917 | Filgotinib only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673918 | Filgotinib only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673918 | Filgotinib only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673919 | Ornidazole only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673919 | Ornidazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673920 | Pediatric SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | British preferred term (PTGB) | NO | |
| RxCUI: 2673920 | Pediatric SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673920 | Pediatric SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673920 | Pediatric SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673920 | Pediatric SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673920 | Pediatric SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673920 | Pediatric SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673921 | Paediatric Hepatitis B recombinant adsorbed surface antigen only vaccine product | British preferred term (PTGB) | NO | |
| RxCUI: 2673921 | Paediatric Hepatitis B recombinant adsorbed surface antigen only vaccine product | Designated preferred name (PT) | NO | |
| RxCUI: 2673921 | Paediatric Hepatitis B recombinant adsorbed surface antigen only vaccine product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673922 | Pediatric diphtheria toxoid and acellular pertussis and tetanus toxoid vaccine | British preferred term (PTGB) | NO | |
| RxCUI: 2673922 | Pediatric diphtheria toxoid and acellular pertussis and tetanus toxoid vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673922 | Pediatric diphtheria toxoid and acellular pertussis and tetanus toxoid vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673922 | Pediatric diphtheria toxoid and acellular pertussis and tetanus toxoid vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673922 | Pediatric diphtheria toxoid and acellular pertussis and tetanus toxoid vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673923 | Product containing only roxithromycin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2673923 | Product containing only roxithromycin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2673924 | Pediatric vaccine inactivated hepatitis A and hepatitis B surface antigen vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673924 | Pediatric vaccine inactivated hepatitis A and hepatitis B surface antigen vaccine | British preferred term (PTGB) | NO | |
| RxCUI: 2673924 | Pediatric vaccine inactivated hepatitis A and hepatitis B surface antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673924 | Pediatric vaccine inactivated hepatitis A and hepatitis B surface antigen vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673924 | Pediatric vaccine inactivated hepatitis A and hepatitis B surface antigen vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673925 | Vaccine product containing only S, preS1, preS2 Hepatitis B virus recombinant surface antigens | Designated preferred name (PT) | NO | |
| RxCUI: 2673925 | Vaccine product containing only S, preS1, preS2 Hepatitis B virus recombinant surface antigens | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673925 | Vaccine product containing only S, preS1, preS2 Hepatitis B virus recombinant surface antigens | Full form of descriptor (FN) | NO | |
| RxCUI: 2673926 | Abrocitinib only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673926 | Abrocitinib only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673927 | Abrocitinib only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673927 | Abrocitinib only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673928 | Caffeine and guaifenesin and paracetamol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673928 | Caffeine and guaifenesin and paracetamol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673928 | Caffeine and guaifenesin and paracetamol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673929 | Dextromethorphan and paracetamol and promethazine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673929 | Dextromethorphan and paracetamol and promethazine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673929 | Dextromethorphan and paracetamol and promethazine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673930 | Dextromethorphan and paracetamol and promethazine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673930 | Dextromethorphan and paracetamol and promethazine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673930 | Dextromethorphan and paracetamol and promethazine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673931 | Guaifenesin and paracetamol and phenylephrine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2673931 | Guaifenesin and paracetamol and phenylephrine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673931 | Guaifenesin and paracetamol and phenylephrine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673932 | Guaifenesin and paracetamol and phenylephrine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673932 | Guaifenesin and paracetamol and phenylephrine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673932 | Guaifenesin and paracetamol and phenylephrine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673933 | Posaconazole only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2673933 | Posaconazole only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2673934 | Adult SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673934 | Adult SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673934 | Adult SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673934 | Adult SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673935 | SARS-CoV-2 original strain spike protein mRNA vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2673935 | SARS-CoV-2 original strain spike protein mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673935 | SARS-CoV-2 original strain spike protein mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673935 | SARS-CoV-2 original strain spike protein mRNA vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2673936 | Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673936 | Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens | Full form of descriptor (FN) | NO | |
| RxCUI: 2673936 | Vaccine product containing only Human-bovine reassortant Rotavirus G1, G2, G3, G4, and P1A[8] antigens | Designated preferred name (PT) | NO | |
| RxCUI: 2673937 | Vaccine product containing only Variola virus antigen (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2673937 | Vaccine product containing only Variola virus antigen (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2673940 | Antigen of Aspergillus terreus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673940 | Antigen of Aspergillus terreus | Full form of descriptor (FN) | NO | |
| RxCUI: 2673940 | Antigen of Aspergillus terreus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673940 | Antigen of Aspergillus terreus | Designated preferred name (PT) | NO | |
| RxCUI: 2673942 | Antigen of enterovirus A71 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673942 | Antigen of enterovirus A71 | Full form of descriptor (FN) | NO | |
| RxCUI: 2673942 | Antigen of enterovirus A71 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673942 | Antigen of enterovirus A71 | Designated preferred name (PT) | NO | |
| RxCUI: 2673944 | Antigen of Fusarium proliferatum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673944 | Antigen of Fusarium proliferatum | Full form of descriptor (FN) | NO | |
| RxCUI: 2673944 | Antigen of Fusarium proliferatum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673944 | Antigen of Fusarium proliferatum | Designated preferred name (PT) | NO | |
| RxCUI: 2673945 | Antigen of Hepatitis B virus preS1 recombinant surface protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673945 | Antigen of Hepatitis B virus preS1 recombinant surface protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2673945 | Antigen of Hepatitis B virus preS1 recombinant surface protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673945 | Antigen of Hepatitis B virus preS1 recombinant surface protein | Designated preferred name (PT) | NO | |
| RxCUI: 2673946 | Antigen of Hepatitis B virus preS2 recombinant surface protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673946 | Antigen of Hepatitis B virus preS2 recombinant surface protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2673946 | Antigen of Hepatitis B virus preS2 recombinant surface protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673946 | Antigen of Hepatitis B virus preS2 recombinant surface protein | Designated preferred name (PT) | NO | |
| RxCUI: 2673947 | Antigen of Hepatitis B virus recombinant surface antigen adsorbed | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673947 | Antigen of Hepatitis B virus recombinant surface antigen adsorbed | Full form of descriptor (FN) | NO | |
| RxCUI: 2673947 | Antigen of Hepatitis B virus recombinant surface antigen adsorbed | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673947 | Antigen of Hepatitis B virus recombinant surface antigen adsorbed | Designated preferred name (PT) | NO | |
| RxCUI: 2673948 | Antigen of Hepatitis B virus S recombinant surface protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673948 | Antigen of Hepatitis B virus S recombinant surface protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2673948 | Antigen of Hepatitis B virus S recombinant surface protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673948 | Antigen of Hepatitis B virus S recombinant surface protein | Designated preferred name (PT) | NO | |
| RxCUI: 2673949 | Antigen of live attenuated Zaire ebolavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673949 | Antigen of live attenuated Zaire ebolavirus | Full form of descriptor (FN) | NO | |
| RxCUI: 2673949 | Antigen of live attenuated Zaire ebolavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673949 | Antigen of live attenuated Zaire ebolavirus | Designated preferred name (PT) | NO | |
| RxCUI: 2673950 | Antigen Zaire ebolavirus | Full form of descriptor (FN) | NO | |
| RxCUI: 2673950 | Antigen Zaire ebolavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673950 | Antigen Zaire ebolavirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673950 | Antigen Zaire ebolavirus | Designated preferred name (PT) | NO | |
| RxCUI: 2673952 | Antigen of modified Vaccinia virus Ankara strain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673952 | Antigen of modified Vaccinia virus Ankara strain | Full form of descriptor (FN) | NO | |
| RxCUI: 2673952 | Antigen of modified Vaccinia virus Ankara strain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673952 | Antigen of modified Vaccinia virus Ankara strain | Designated preferred name (PT) | NO | |
| RxCUI: 2673952 | Antigen of modified Vaccinia virus Ankara strain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673953 | Antigen of Neocamarosporium betae | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673953 | Antigen of Neocamarosporium betae | Full form of descriptor (FN) | NO | |
| RxCUI: 2673953 | Antigen of Neocamarosporium betae | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673953 | Antigen of Neocamarosporium betae | Designated preferred name (PT) | NO | |
| RxCUI: 2673953 | Antigen of Neocamarosporium betae | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673954 | Antigen of Orthopneumovirus hominis recombinant surface glycoprotein F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673954 | Antigen of Orthopneumovirus hominis recombinant surface glycoprotein F | Full form of descriptor (FN) | NO | |
| RxCUI: 2673954 | Antigen of Orthopneumovirus hominis recombinant surface glycoprotein F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673954 | Antigen of Orthopneumovirus hominis recombinant surface glycoprotein F | Designated preferred name (PT) | NO | |
| RxCUI: 2673954 | Antigen of Orthopneumovirus hominis recombinant surface glycoprotein F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673954 | Antigen of Orthopneumovirus hominis recombinant surface glycoprotein F | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673956 | Vaccine product containing Plasmodium falciparum antigen | Designated preferred name (PT) | NO | |
| RxCUI: 2673956 | Vaccine product containing Plasmodium falciparum antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673956 | Vaccine product containing Plasmodium falciparum antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 2673957 | Protozoa antigen-containing vaccine product | Designated preferred name (PT) | NO | |
| RxCUI: 2673957 | Protozoa antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
| RxCUI: 2673958 | Vaccine product containing Variola virus antigen (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2673958 | Vaccine product containing Variola virus antigen (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 267396 | Bupivacaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 267396 | Bupivacaine hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 267396 | Bupivacaine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 267396 | Bupivacaine hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 2673960 | Botulinum toxin type B and/or botulinum toxin type B derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2673960 | Botulinum toxin type B and/or botulinum toxin type B derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2673961 | Botulinum toxin type C | Designated preferred name (PT) | NO | |
| RxCUI: 2673961 | Botulinum toxin type C | Full form of descriptor (FN) | NO | |
| RxCUI: 2673962 | Botulinum toxin type D | Designated preferred name (PT) | NO | |
| RxCUI: 2673962 | Botulinum toxin type D | Full form of descriptor (FN) | NO | |
| RxCUI: 2673963 | Botulinum toxin type E | Designated preferred name (PT) | NO | |
| RxCUI: 2673963 | Botulinum toxin type E | Full form of descriptor (FN) | NO | |
| RxCUI: 2673964 | Botulinum toxin type G | Designated preferred name (PT) | NO | |
| RxCUI: 2673964 | Botulinum toxin type G | Full form of descriptor (FN) | NO | |
| RxCUI: 2673965 | Botulinum toxoid type A | Designated preferred name (PT) | NO | |
| RxCUI: 2673965 | Botulinum toxoid type A | Full form of descriptor (FN) | NO | |
| RxCUI: 2673966 | Botulinum toxoid type B | Designated preferred name (PT) | NO | |
| RxCUI: 2673966 | Botulinum toxoid type B | Full form of descriptor (FN) | NO | |
| RxCUI: 2673967 | Botulinum toxoid type C | Designated preferred name (PT) | NO | |
| RxCUI: 2673967 | Botulinum toxoid type C | Full form of descriptor (FN) | NO | |
| RxCUI: 2673968 | Botulinum toxoid type D | Designated preferred name (PT) | NO | |
| RxCUI: 2673968 | Botulinum toxoid type D | Full form of descriptor (FN) | NO | |
| RxCUI: 2673969 | Botulinum toxoid type E | Designated preferred name (PT) | NO | |
| RxCUI: 2673969 | Botulinum toxoid type E | Full form of descriptor (FN) | NO | |
| RxCUI: 2673970 | Botulinum toxoid type F | Designated preferred name (PT) | NO | |
| RxCUI: 2673970 | Botulinum toxoid type F | Full form of descriptor (FN) | NO | |
| RxCUI: 2673971 | Botulinum toxoid type G | Designated preferred name (PT) | NO | |
| RxCUI: 2673971 | Botulinum toxoid type G | Full form of descriptor (FN) | NO | |
| RxCUI: 2673972 | Aeromonas enterotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673972 | Aeromonas enterotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673973 | Bacterial enterotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673973 | Bacterial enterotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673974 | Clostridium difficile enterotoxin A | Designated preferred name (PT) | NO | |
| RxCUI: 2673974 | Clostridium difficile enterotoxin A | Full form of descriptor (FN) | NO | |
| RxCUI: 2673975 | Clostridium perfringens enterotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673975 | Clostridium perfringens enterotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673976 | Cytotoxic enterotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673976 | Cytotoxic enterotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673978 | Plesiomonas heat-stable enterotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673978 | Plesiomonas heat-stable enterotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673979 | Staphylococcus aureus enterotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673979 | Staphylococcus aureus enterotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673980 | Staphylococcus aureus enterotoxin E | Designated preferred name (PT) | NO | |
| RxCUI: 2673980 | Staphylococcus aureus enterotoxin E | Full form of descriptor (FN) | NO | |
| RxCUI: 2673981 | Staphylococcus aureus enterotoxin G | Designated preferred name (PT) | NO | |
| RxCUI: 2673981 | Staphylococcus aureus enterotoxin G | Full form of descriptor (FN) | NO | |
| RxCUI: 2673982 | Viral enterotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673982 | Viral enterotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673983 | Yersinia enterotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673983 | Yersinia enterotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673984 | Bacterial cytotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673984 | Bacterial cytotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673985 | Campylobacter cytotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673985 | Campylobacter cytotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673986 | Salmonella cytotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673986 | Salmonella cytotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673987 | VT - Verotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673987 | VT - Verotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673987 | VT - Verotoxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673987 | VT - Verotoxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673988 | Verocytotoxin IIII | Designated preferred name (PT) | NO | |
| RxCUI: 2673988 | Verocytotoxin IIII | Full form of descriptor (FN) | NO | |
| RxCUI: 2673989 | Verocytotoxin IIv | Designated preferred name (PT) | NO | |
| RxCUI: 2673989 | Verocytotoxin IIv | Full form of descriptor (FN) | NO | |
| RxCUI: 2673990 | Heat labile bacterial toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673990 | Heat labile bacterial toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673991 | Heat stable bacterial toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673991 | Heat stable bacterial toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673992 | Bacterial toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673992 | Bacterial toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673993 | Endotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673993 | Endotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673993 | Endotoxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673994 | Exotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673994 | Exotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673994 | Exotoxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673995 | Escherichia coli heat-labile toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673995 | Escherichia coli heat-labile toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673996 | Escherichia coli heat-stable toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673996 | Escherichia coli heat-stable toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673997 | Escherichia coli heat-stable-like toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673997 | Escherichia coli heat-stable-like toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673998 | Colitoxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2673998 | Colitoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673998 | Colitoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2673999 | Escherichia coli verotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2673999 | Escherichia coli verotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674000 | Clostridial toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674000 | Clostridial toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674001 | Clostridium difficile toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674001 | Clostridium difficile toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674002 | Clostridium difficile cytotoxin B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674002 | Clostridium difficile cytotoxin B | Designated preferred name (PT) | NO | |
| RxCUI: 2674002 | Clostridium difficile cytotoxin B | Full form of descriptor (FN) | NO | |
| RxCUI: 2674003 | Clostridium perfringens beta toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674003 | Clostridium perfringens beta toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674004 | Clostridium perfringens epsilon toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674004 | Clostridium perfringens epsilon toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674005 | Clostridium perfringens iota toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674005 | Clostridium perfringens iota toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674006 | Clostridium welchii toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674006 | Clostridium welchii toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674006 | Clostridium welchii toxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674007 | Clostridium tetani toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674007 | Clostridium tetani toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674008 | Cholera toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674008 | Cholera toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674009 | Cholera-like toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674009 | Cholera-like toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674010 | Corynebacterium spp toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674010 | Corynebacterium spp toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674011 | Diphtheria toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674011 | Diphtheria toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674012 | Staphylococcus aureus toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674012 | Staphylococcus aureus toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674013 | Staphylococcal toxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674013 | Staphylococcal toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674013 | Staphylococcal toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674014 | Streptococcal toxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674014 | Streptococcal toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674014 | Streptococcal toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674015 | Pasteurella multocida toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674015 | Pasteurella multocida toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674016 | Shiga toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674016 | Shiga toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674017 | Stx-1 - Shiga toxin 1 | Designated preferred name (PT) | NO | |
| RxCUI: 2674017 | Stx-1 - Shiga toxin 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 2674017 | Stx-1 - Shiga toxin 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674018 | Stx-2 - Shiga toxin 2 | Designated preferred name (PT) | NO | |
| RxCUI: 2674018 | Stx-2 - Shiga toxin 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 2674018 | Stx-2 - Shiga toxin 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674019 | Pertussis toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674019 | Pertussis toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674020 | Bacillus cereus toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2674020 | Bacillus cereus toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674021 | Verocytotoxin I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674021 | Verocytotoxin I | Designated preferred name (PT) | NO | |
| RxCUI: 2674021 | Verocytotoxin I | Full form of descriptor (FN) | NO | |
| RxCUI: 2674022 | Verotoxin 2 | Designated preferred name (PT) | NO | |
| RxCUI: 2674022 | Verotoxin 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 2674051 | Caffeine- and guaifenesin- and paracetamol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2674051 | Caffeine- and guaifenesin- and paracetamol-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674051 | Caffeine- and guaifenesin- and paracetamol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2674052 | Dextromethorphan- and paracetamol- and promethazine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2674052 | Dextromethorphan- and paracetamol- and promethazine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674052 | Dextromethorphan- and paracetamol- and promethazine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2674054 | Dextromethorphan- and paracetamol- and promethazine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2674054 | Dextromethorphan- and paracetamol- and promethazine-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674054 | Dextromethorphan- and paracetamol- and promethazine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2674055 | ethanol 83 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2674055 | ethanol 83 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2674055 | ethanol 83 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674058 | Ceftobiprole-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2674058 | Ceftobiprole-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2674059 | Chlorhexidine digluconate 2.5 mg/g and phenol 12 mg/g cutaneous cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674060 | Chlortalidone- and olmesartan-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674060 | Chlortalidone- and olmesartan-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2674060 | Chlortalidone- and olmesartan-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2674061 | Chlortalidone- and olmesartan-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674061 | Chlortalidone- and olmesartan-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2674061 | Chlortalidone- and olmesartan-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2674062 | Cilnidipine- and olmesartan-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2674062 | Cilnidipine- and olmesartan-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2674063 | Cilnidipine- and olmesartan-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2674063 | Cilnidipine- and olmesartan-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2674064 | Ciclosporin 50 mg/mL concentrate for solution for infusion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674064 | Ciclosporin 50 mg/mL concentrate for solution for infusion | Designated preferred name (PT) | NO | |
| RxCUI: 2674064 | Ciclosporin 50 mg/mL concentrate for solution for infusion | Full form of descriptor (FN) | NO | |
| RxCUI: 2674065 | Dexamethasone- and levofloxacin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2674065 | Dexamethasone- and levofloxacin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2674066 | Dexamethasone- and levofloxacin-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2674066 | Dexamethasone- and levofloxacin-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2674068 | Filgotinib-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2674068 | Filgotinib-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2674069 | Gimeracil- and oteracil- and tegafur-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2674069 | Gimeracil- and oteracil- and tegafur-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2674070 | Gimeracil- and oteracil- and tegafur-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2674070 | Gimeracil- and oteracil- and tegafur-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2674071 | Phytocannabinoid | Designated preferred name (PT) | NO | |
| RxCUI: 2674071 | Phytocannabinoid | Full form of descriptor (FN) | NO | |
| RxCUI: 2674071 | Phytocannabinoid | Designated preferred name (PT) | NO | |
| RxCUI: 2674071 | Phytocannabinoid | Full form of descriptor (FN) | NO | |
| RxCUI: 2674072 | Posaconazole 18 mg/mL concentrate for solution for infusion | Designated preferred name (PT) | NO | |
| RxCUI: 2674072 | Posaconazole 18 mg/mL concentrate for solution for infusion | Full form of descriptor (FN) | NO | |
| RxCUI: 2674074 | Product containing roxadustat in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674074 | Product containing roxadustat in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2674075 | Product containing sodium alginate in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674075 | Product containing sodium alginate in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2674076 | Product containing taurolidine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674076 | Product containing taurolidine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2674077 | Product containing precisely trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674077 | Product containing precisely trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2674079 | Endocannabinoid | Designated preferred name (PT) | NO | |
| RxCUI: 2674079 | Endocannabinoid | Full form of descriptor (FN) | NO | |
| RxCUI: 2674081 | Abiraterone acetate 1 g oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2674081 | Abiraterone acetate 1 g oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674082 | Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2674082 | Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674082 | Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2674083 | Acetaminophen 500 mg and caffeine 30 mg and codeine phosphate 8 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2674083 | Acetaminophen 500 mg and caffeine 30 mg and codeine phosphate 8 mg oral capsule | British preferred term (PTGB) | NO | |
| RxCUI: 2674083 | Acetaminophen 500 mg and caffeine 30 mg and codeine phosphate 8 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2674084 | Codeine phosphate 15 mg and paracetamol 500 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2674084 | Codeine phosphate 15 mg and paracetamol 500 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674084 | Codeine phosphate 15 mg and paracetamol 500 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2674085 | Dextromethorphan hydrobromide 7.5 mg and paracetamol 500 mg and promethazine hydrochloride 10 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2674085 | Dextromethorphan hydrobromide 7.5 mg and paracetamol 500 mg and promethazine hydrochloride 10 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674085 | Dextromethorphan hydrobromide 7.5 mg and paracetamol 500 mg and promethazine hydrochloride 10 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2674086 | Guaifenesin 100 mg and paracetamol 500 mg and phenylephrine (as phenylephrine hydrochloride) 5 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2674086 | Guaifenesin 100 mg and paracetamol 500 mg and phenylephrine (as phenylephrine hydrochloride) 5 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674086 | Guaifenesin 100 mg and paracetamol 500 mg and phenylephrine (as phenylephrine hydrochloride) 5 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 267417 | cefsulodin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 26742 | Antigen of Hepatitis A virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26742 | Antigen of Hepatitis A virus | Full form of descriptor (FN) | NO | |
| RxCUI: 26742 | Antigen of Hepatitis A virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26742 | Antigen of Hepatitis A virus | Designated preferred name (PT) | NO | |
| RxCUI: 2674255 | Calcifediol 255 microgram oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2674255 | Calcifediol 255 microgram oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2674256 | Calcium carbonate 32.5 mg/mL and sodium alginate 50 mg/mL and sodium hydrogen carbonate 21.3 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2674256 | Calcium carbonate 32.5 mg/mL and sodium alginate 50 mg/mL and sodium hydrogen carbonate 21.3 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674256 | Calcium carbonate 32.5 mg/mL and sodium alginate 50 mg/mL and sodium hydrogen carbonate 21.3 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2674258 | Ceftobiprole (as ceftobiprole medocaril sodium) 500 mg powder for solution for infusion vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674258 | Ceftobiprole (as ceftobiprole medocaril sodium) 500 mg powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674259 | Ceftobiprole medocaril sodium | Designated preferred name (PT) | NO | |
| RxCUI: 2674259 | Ceftobiprole medocaril sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 2674260 | Cefalotin (as cefalotin sodium) 2 g powder for solution for infusion and/or injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674260 | Cefalotin (as cefalotin sodium) 2 g powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674260 | Cefalotin (as cefalotin sodium) 2 g powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674261 | Cefalotin (as cefalotin sodium) 2 g powder for solution for injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674261 | Cefalotin (as cefalotin sodium) 2 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674261 | Cefalotin (as cefalotin sodium) 2 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674262 | Clindamycin (as clindamycin phosphate) 150 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
| RxCUI: 2674262 | Clindamycin (as clindamycin phosphate) 150 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
| RxCUI: 2674263 | Clindamycin (as clindamycin phosphate) 150 mg/mL solution for infusion and/or injection | Designated preferred name (PT) | NO | |
| RxCUI: 2674263 | Clindamycin (as clindamycin phosphate) 150 mg/mL solution for infusion and/or injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2674264 | Isoniazid 75 mg and rifampicin 150 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674264 | Isoniazid 75 mg and rifampicin 150 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2674264 | Isoniazid 75 mg and rifampicin 150 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674265 | Cloxacillin (as cloxacillin sodium) 1 g powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674265 | Cloxacillin (as cloxacillin sodium) 1 g powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674266 | Cloxacillin (as cloxacillin sodium) 1 g powder for solution for infusion vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674266 | Cloxacillin (as cloxacillin sodium) 1 g powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674267 | Cloxacillin (as cloxacillin sodium) 2 g powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674267 | Cloxacillin (as cloxacillin sodium) 2 g powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674268 | Cloxacillin (as cloxacillin sodium) 2 g powder for solution for infusion vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674268 | Cloxacillin (as cloxacillin sodium) 2 g powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674297 | American red raspberry specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674297 | American red raspberry specific immunoglobulin E | Designated preferred name (PT) | NO | |
| RxCUI: 2674297 | American red raspberry specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674297 | American red raspberry specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674297 | American red raspberry specific immunoglobulin E | Full form of descriptor (FN) | NO | |
| RxCUI: 2674297 | American red raspberry specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674298 | Mesalazine 1 g gastro-resistant and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2674298 | Mesalazine 1 g gastro-resistant and prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674298 | Mesalazine 1 g gastro-resistant and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674299 | Mesalazine 1.5 g gastro-resistant and prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2674299 | Mesalazine 1.5 g gastro-resistant and prolonged-release oral granules sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674299 | Mesalazine 1.5 g gastro-resistant and prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 26743 | Hepatitis A virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26743 | Hepatitis A virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26743 | Hepatitis A virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 26743 | Hepatitis A virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 26743 | Hepatitis A virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26743 | Hepatitis A virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26743 | Hepatitis A virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674300 | Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2674300 | Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674300 | Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674301 | Mesalazine 2 g gastro-resistant and prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2674301 | Mesalazine 2 g gastro-resistant and prolonged-release oral granules sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674301 | Mesalazine 2 g gastro-resistant and prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674302 | Product containing precisely taurolidine 20 milligram/1 milliliter conventional release solution for intraperitoneal instillation (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674302 | Product containing precisely taurolidine 20 milligram/1 milliliter conventional release solution for intraperitoneal instillation (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2674303 | Tetanolysin | Designated preferred name (PT) | NO | |
| RxCUI: 2674303 | Tetanolysin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674304 | Tetanospasmin | Designated preferred name (PT) | NO | |
| RxCUI: 2674304 | Tetanospasmin | Full form of descriptor (FN) | NO | |
| RxCUI: 2674305 | Dexamethasone (as dexamethasone sodium phosphate) 1 mg/mL and levofloxacin 5 mg/mL eye drops solution | Designated preferred name (PT) | NO | |
| RxCUI: 2674305 | Dexamethasone (as dexamethasone sodium phosphate) 1 mg/mL and levofloxacin 5 mg/mL eye drops solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2674306 | Dexamethasone 1 mg/1 mL and neomycin (as neomycin sulfate) 3500 unit/1 mL and polymyxin B sulfate 6000 unit/1 mL eye drops suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2674306 | Dexamethasone 1 mg/1 mL and neomycin (as neomycin sulfate) 3500 unit/1 mL and polymyxin B sulfate 6000 unit/1 mL eye drops suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2674307 | Mesalazine 3 g gastro-resistant and prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2674307 | Mesalazine 3 g gastro-resistant and prolonged-release oral granules sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674307 | Mesalazine 3 g gastro-resistant and prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674308 | Mesalazine 4 g gastro-resistant and prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2674308 | Mesalazine 4 g gastro-resistant and prolonged-release oral granules sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674308 | Mesalazine 4 g gastro-resistant and prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674309 | Mesalazine 500 mg gastro-resistant and prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2674309 | Mesalazine 500 mg gastro-resistant and prolonged-release oral granules sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674309 | Mesalazine 500 mg gastro-resistant and prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674310 | Rotavirus NSP4 nonstructural glycoprotein | Designated preferred name (PT) | NO | |
| RxCUI: 2674310 | Rotavirus NSP4 nonstructural glycoprotein | Full form of descriptor (FN) | NO | |
| RxCUI: 2674311 | Product containing precisely roxadustat 100 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674311 | Product containing precisely roxadustat 100 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2674312 | Product containing precisely roxadustat 150 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674312 | Product containing precisely roxadustat 150 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2674313 | Product containing precisely roxadustat 20 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674313 | Product containing precisely roxadustat 20 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2674314 | Product containing precisely roxadustat 50 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674314 | Product containing precisely roxadustat 50 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2674315 | Product containing precisely roxadustat 70 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674315 | Product containing precisely roxadustat 70 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2674316 | Empagliflozin 12.5 mg and metformin hydrochloride 850 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2674316 | Empagliflozin 12.5 mg and metformin hydrochloride 850 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674317 | Metformin hydrochloride 850 mg and saxagliptin (as saxagliptin hydrochloride) 2.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2674317 | Metformin hydrochloride 850 mg and saxagliptin (as saxagliptin hydrochloride) 2.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674318 | Metronidazole 500 mg vaginal pessary | Designated preferred name (PT) | NO | |
| RxCUI: 2674318 | Metronidazole 500 mg vaginal pessary | Full form of descriptor (FN) | NO | |
| RxCUI: 2674320 | Escitalopram (as escitalopram oxalate) 15 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2674320 | Escitalopram (as escitalopram oxalate) 15 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674321 | Etanercept 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2674321 | Etanercept 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2674322 | Ezetimibe 10 mg and rosuvastatin (as rosuvastatin zinc) 10 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2674322 | Ezetimibe 10 mg and rosuvastatin (as rosuvastatin zinc) 10 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2674323 | Ezetimibe 10 mg and rosuvastatin (as rosuvastatin zinc) 20 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2674323 | Ezetimibe 10 mg and rosuvastatin (as rosuvastatin zinc) 20 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2674324 | Antibody to complement factor H | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674324 | Antibody to complement factor H | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674324 | Antibody to complement factor H | Full form of descriptor (FN) | NO | |
| RxCUI: 2674324 | Antibody to complement factor H | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674324 | Antibody to complement factor H | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674324 | Antibody to complement factor H | Designated preferred name (PT) | NO | |
| RxCUI: 2674324 | Antibody to complement factor H | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674325 | Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge | Designated preferred name (PT) | NO | |
| RxCUI: 2674325 | Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge | Full form of descriptor (FN) | NO | |
| RxCUI: 2674326 | Nicotine pouch | Designated preferred name (PT) | NO | |
| RxCUI: 2674326 | Nicotine pouch | Full form of descriptor (FN) | NO | |
| RxCUI: 2674328 | Omega-3-acid ethyl esters 90 | Designated preferred name (PT) | NO | |
| RxCUI: 2674328 | Omega-3-acid ethyl esters 90 | Full form of descriptor (FN) | NO | |
| RxCUI: 2674367 | Product containing precisely propofol 10 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2674367 | Product containing precisely propofol 10 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2674368 | Solenopsis invicta venom | Designated preferred name (PT) | NO | |
| RxCUI: 2674368 | Solenopsis invicta venom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674368 | Solenopsis invicta venom | Full form of descriptor (FN) | NO | |
| RxCUI: 2674369 | Rifampicin 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674369 | Rifampicin 300 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674369 | Rifampicin 300 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 267437 | Cyclophosphamide monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 267437 | Cyclophosphamide monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2674370 | Rifampicin 300 mg powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674370 | Rifampicin 300 mg powder for solution for infusion vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674370 | Rifampicin 300 mg powder for solution for infusion vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674371 | Filgotinib (as filgotinib maleate) 100 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2674371 | Filgotinib (as filgotinib maleate) 100 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674372 | Filgotinib (as filgotinib maleate) 200 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2674372 | Filgotinib (as filgotinib maleate) 200 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674373 | Fusidic acid 10 mg/g eye drops suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2674373 | Fusidic acid 10 mg/g eye drops suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2674374 | Gimeracil 4.35 mg and oteracil (as oteracil potassium) 11.8 mg and tegafur 15 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2674374 | Gimeracil 4.35 mg and oteracil (as oteracil potassium) 11.8 mg and tegafur 15 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2674375 | Gimeracil 5.8 mg and oteracil (as oteracil potassium) 15.8 mg and tegafur 20 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2674375 | Gimeracil 5.8 mg and oteracil (as oteracil potassium) 15.8 mg and tegafur 20 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2674377 | Messenger ribonucleic acid of 2019-nCoV encoding B lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674377 | Messenger ribonucleic acid of 2019-nCoV encoding B lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674377 | Messenger ribonucleic acid of 2019-nCoV encoding B lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674377 | Messenger ribonucleic acid of 2019-nCoV encoding B lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674377 | Messenger ribonucleic acid of 2019-nCoV encoding B lineage spike protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2674377 | Messenger ribonucleic acid of 2019-nCoV encoding B lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674377 | Messenger ribonucleic acid of 2019-nCoV encoding B lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674377 | Messenger ribonucleic acid of 2019-nCoV encoding B lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674377 | Messenger ribonucleic acid of 2019-nCoV encoding B lineage spike protein | Designated preferred name (PT) | NO | |
| RxCUI: 2674378 | Messenger ribonucleic acid of 2019-nCoV encoding BA.4/BA.5 lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674378 | Messenger ribonucleic acid of 2019-nCoV encoding BA.4/BA.5 lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674378 | Messenger ribonucleic acid of 2019-nCoV encoding BA.4/BA.5 lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674378 | Messenger ribonucleic acid of 2019-nCoV encoding BA.4/BA.5 lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674378 | Messenger ribonucleic acid of 2019-nCoV encoding BA.4/BA.5 lineage spike protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2674378 | Messenger ribonucleic acid of 2019-nCoV encoding BA.4/BA.5 lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674378 | Messenger ribonucleic acid of 2019-nCoV encoding BA.4/BA.5 lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674378 | Messenger ribonucleic acid of 2019-nCoV encoding BA.4/BA.5 lineage spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674378 | Messenger ribonucleic acid of 2019-nCoV encoding BA.4/BA.5 lineage spike protein | Designated preferred name (PT) | NO | |
| RxCUI: 2674379 | Bombyx mori (moth) specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674379 | Bombyx mori (moth) specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674379 | Bombyx mori (moth) specific immunoglobulin E | Full form of descriptor (FN) | NO | |
| RxCUI: 2674379 | Bombyx mori (moth) specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674379 | Bombyx mori (moth) specific immunoglobulin E | Designated preferred name (PT) | NO | |
| RxCUI: 2674380 | Pentamidine isethionate 300 mg powder for nebulizer solution vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674380 | Pentamidine isethionate 300 mg powder for nebulizer solution vial | British preferred term (PTGB) | NO | |
| RxCUI: 2674380 | Pentamidine isethionate 300 mg powder for nebulizer solution vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674381 | 2-arachidonoylglycerol | Designated preferred name (PT) | NO | |
| RxCUI: 2674381 | 2-arachidonoylglycerol | Full form of descriptor (FN) | NO | |
| RxCUI: 2674382 | Anti-actin antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2674382 | Anti-actin antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 2674382 | Anti-actin antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674383 | Aciclovir 50 mg/g cutaneous stick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674383 | Aciclovir 50 mg/g cutaneous stick | Designated preferred name (PT) | NO | |
| RxCUI: 2674383 | Aciclovir 50 mg/g cutaneous stick | Full form of descriptor (FN) | NO | |
| RxCUI: 2674385 | Pivmecillinam hydrochloride 400 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2674385 | Pivmecillinam hydrochloride 400 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674385 | Pivmecillinam hydrochloride 400 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2674386 | Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebuliser vial | British preferred term (PTGB) | NO | |
| RxCUI: 2674386 | Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebuliser vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674386 | Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebuliser vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674387 | Amoxicillin (as amoxicillin sodium) 500 mg and clavulanic acid (as clavulanate potassium) 50 mg powder for solution for infusion and/or injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674387 | Amoxicillin (as amoxicillin sodium) 500 mg and clavulanic acid (as clavulanate potassium) 50 mg powder for solution for infusion and/or injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674388 | Amoxicillin (as amoxicillin sodium) 500 mg and clavulanic acid (as clavulanate potassium) 50 mg powder for solution for infusion vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674388 | Amoxicillin (as amoxicillin sodium) 500 mg and clavulanic acid (as clavulanate potassium) 50 mg powder for solution for infusion vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674389 | Amoxicillin (as amoxicillin sodium) 500 mg and clavulanic acid (as clavulanate potassium) 50 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2674389 | Amoxicillin (as amoxicillin sodium) 500 mg and clavulanic acid (as clavulanate potassium) 50 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2674390 | Anandamide | Designated preferred name (PT) | NO | |
| RxCUI: 2674390 | Anandamide | Full form of descriptor (FN) | NO | |
| RxCUI: 2674391 | Bispecific monoclonal antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2674391 | Bispecific monoclonal antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 26744 | hepatitis B immunoglobin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 26744 | hepatitis B immunoglobin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 26744 | hepatitis B immunoglobin | Designated preferred name (PT) | YES | |
| RxCUI: 26744 | hepatitis B immunoglobin | Full form of descriptor (FN) | YES | |
| RxCUI: 26744 | hepatitis B immunoglobin | Designated preferred name (PT) | YES | |
| RxCUI: 26744 | hepatitis B immunoglobin | Full form of descriptor (FN) | YES | |
| RxCUI: 267453 | sodium acetate, anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 267467 | Apomorphine hydrochloride anhydrous | Designated preferred name (PT) | NO | |
| RxCUI: 267467 | Apomorphine hydrochloride anhydrous | Full form of descriptor (FN) | NO | |
| RxCUI: 2674672 | lidocaine / phenylephrine / witch hazel Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2674673 | lidocaine / phenylephrine / witch hazel Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2674677 | lidocaine 5 % / phenylephrine HCl 0.25 % / witch hazel 50 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2674677 | lidocaine 5 % / phenylephrine HCl 0.25 % / witch hazel 50 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2674677 | lidocaine 5 % / phenylephrine HCl 0.25 % / witch hazel 50 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 267476 | Azathioprine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 267476 | Azathioprine sodium | Designated preferred name (PT) | YES | |
| RxCUI: 267476 | Azathioprine sodium | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 267476 | Azathioprine sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 2674931 | ixekizumab 20 MG in 0.25 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2674931 | ixekizumab 20 MG in 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2674931 | ixekizumab 20 MG in 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2674932 | taltz 20 MG in 0.25 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2674932 | taltz 20 MG in 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2674932 | taltz 20 MG in 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2674932 | taltz 20 MG in 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2674933 | ixekizumab 40 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2674933 | ixekizumab 40 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2674933 | ixekizumab 40 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2674934 | taltz 40 MG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2674934 | taltz 40 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2674934 | taltz 40 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2674934 | taltz 40 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2674950 | camphor 5.5 % / menthol 16 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2674950 | camphor 5.5 % / menthol 16 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2674950 | camphor 5.5 % / menthol 16 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675021 | methyl salicylate 0.001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675022 | lidocaine 4 % / menthol 0.5 % / methyl salicylate 0.1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675022 | lidocaine 4 % / menthol 0.5 % / methyl salicylate 0.1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675022 | lidocaine 4 % / menthol 0.5 % / methyl salicylate 0.1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675023 | lidocaine 0.04 MG/MG / menthol 0.005 MG/MG / methyl salicylate 0.001 MG/MG [LidoPro Patch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675024 | LidoPro Patch 4 % / 0.5 % / 0.1 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675024 | LidoPro Patch 4 % / 0.5 % / 0.1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675024 | LidoPro Patch 4 % / 0.5 % / 0.1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675096 | chlorhexidine gluconate 4 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675096 | chlorhexidine gluconate 4 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675096 | chlorhexidine gluconate 4 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675185 | eltrombopag choline | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2675186 | eltrombopag 18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675187 | eltrombopag 18 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675187 | eltrombopag 18 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675187 | eltrombopag 18 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675188 | Alvaiz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675189 | eltrombopag 18 MG [Alvaiz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675190 | Alvaiz Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675191 | Alvaiz Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675192 | eltrombopag Oral Tablet [Alvaiz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675193 | Alvaiz 18 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675193 | Alvaiz 18 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675193 | Alvaiz 18 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675193 | Alvaiz 18 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675194 | eltrombopag 36 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675195 | eltrombopag 36 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675195 | eltrombopag 36 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675195 | eltrombopag 36 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675196 | eltrombopag 36 MG [Alvaiz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675197 | Alvaiz 36 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675197 | Alvaiz 36 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675197 | Alvaiz 36 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675197 | Alvaiz 36 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675198 | eltrombopag 54 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675199 | eltrombopag 54 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675199 | eltrombopag 54 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675199 | eltrombopag 54 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675200 | eltrombopag 54 MG [Alvaiz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675201 | Alvaiz 54 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675201 | Alvaiz 54 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675201 | Alvaiz 54 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675201 | Alvaiz 54 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675202 | eltrombopag 9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675203 | eltrombopag 9 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675203 | eltrombopag 9 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675203 | eltrombopag 9 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675204 | eltrombopag 9 MG [Alvaiz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675205 | Alvaiz 9 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675205 | Alvaiz 9 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675205 | Alvaiz 9 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675205 | Alvaiz 9 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675277 | budesonide 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675278 | budesonide Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2675279 | budesonide Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2675280 | budesonide 2 MG per 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675280 | budesonide 2 MG per 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675280 | budesonide 2 MG per 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675281 | Eohilia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675282 | budesonide 0.2 MG/ML [Eohilia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675283 | Eohilia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675284 | Eohilia Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675285 | budesonide Oral Suspension [Eohilia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675286 | Eohilia 2 MG per 10 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675286 | Eohilia 2 MG per 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675286 | Eohilia 2 MG per 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675286 | Eohilia 2 MG per 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675287 | nedosiran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2675288 | nedosiran sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2675289 | capsaicin 0.25 MG/ML [Zostrix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675290 | Zostrix 0.025 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675290 | Zostrix 0.025 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675290 | Zostrix 0.025 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675290 | Zostrix 0.025 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675297 | Impatiens irvingii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2675298 | chlorhexidine acetate 3.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2675299 | chlorhexidine acetate 0.35 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675299 | chlorhexidine acetate 0.35 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675299 | chlorhexidine acetate 0.35 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675300 | nedosiran 160 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675301 | nedosiran Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2675302 | nedosiran Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2675303 | nedosiran 80 MG in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675303 | nedosiran 80 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675303 | nedosiran 80 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675304 | nedosiran 160 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675305 | Rivfloza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675306 | nedosiran 160 MG/ML [Rivfloza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675307 | Rivfloza Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675308 | nedosiran Injection [Rivfloza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675309 | rivfloza 80 MG in 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675309 | rivfloza 80 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675309 | rivfloza 80 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675309 | rivfloza 80 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675310 | nedosiran 160 MG/ML Injection [Rivfloza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675310 | nedosiran 160 MG/ML Injection [Rivfloza] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675311 | nedosiran Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2675312 | nedosiran 128 MG in 0.8 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675312 | nedosiran 128 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675312 | nedosiran 128 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675313 | nedosiran 160 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675314 | nedosiran Prefilled Syringe [Rivfloza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675315 | rivfloza 128 MG in 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675315 | rivfloza 128 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675315 | rivfloza 128 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675315 | rivfloza 128 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675316 | nedosiran 160 MG/ML Prefilled Syringe [Rivfloza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675316 | nedosiran 160 MG/ML Prefilled Syringe [Rivfloza] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675317 | nedosiran 160 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675317 | nedosiran 160 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675317 | nedosiran 160 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675318 | rivfloza 160 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675318 | rivfloza 160 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675318 | rivfloza 160 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675318 | rivfloza 160 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675319 | salicylic acid 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675319 | salicylic acid 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675319 | salicylic acid 4 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675320 | alpha bisabolene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2675321 | Caelyx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675322 | doxorubicin hydrochloride liposome 2 MG/ML [Caelyx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675322 | doxorubicin hydrochloride liposome 2 MG/ML [Caelyx] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675323 | Caelyx Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675324 | doxorubicin Injection [Caelyx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675324 | doxorubicin Injection [Caelyx] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675325 | doxorubicin hydrochloride liposome Injection [Caelyx] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675326 | Caelyx 20 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675326 | Caelyx 20 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675326 | Caelyx 20 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675326 | Caelyx 20 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675326 | Caelyx 20 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675327 | doxorubicin hydrochloride liposome 2 MG/ML Injection [Caelyx] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675327 | doxorubicin hydrochloride liposome 2 MG/ML Injection [Caelyx] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675327 | doxorubicin hydrochloride liposome 2 MG/ML Injection [Caelyx] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2675343 | azulene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2675350 | HYDROmorphone hydrochloride 0.25 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675350 | HYDROmorphone hydrochloride 0.25 MG in 0.5 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675350 | HYDROmorphone hydrochloride 0.25 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675350 | HYDROmorphone hydrochloride 0.25 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675350 | HYDROmorphone hydrochloride 0.25 MG in 0.5 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675354 | Product containing precisely propofol 10 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2675354 | Product containing precisely propofol 10 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2675366 | povidone-iodine Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2675367 | povidone-iodine Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2675368 | povidone-iodine Nasal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2675369 | povidone-iodine 1 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675369 | povidone-iodine 1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675369 | povidone-iodine 1 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675381 | Mesalazine 500 mg gastro-resistant and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2675381 | Mesalazine 500 mg gastro-resistant and prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675381 | Mesalazine 500 mg gastro-resistant and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2675386 | Budesonide 3 mg gastro-resistant and prolonged-release oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2675386 | Budesonide 3 mg gastro-resistant and prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2675387 | Mesalamine 1.2 g gastro-resistant and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2675387 | Mesalamine 1.2 g gastro-resistant and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2675388 | Mesalamine 400 mg gastro-resistant and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2675388 | Mesalamine 400 mg gastro-resistant and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2675389 | Mesalamine 800 mg gastro-resistant and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2675389 | Mesalamine 800 mg gastro-resistant and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2675390 | Mesalamine 250 mg gastro-resistant and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2675390 | Mesalamine 250 mg gastro-resistant and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2675485 | Mometavet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2675486 | clotrimazole 10 MG/ML / gentamicin 3 MG/ML / mometasone 1 MG/ML [Mometavet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2675487 | Mometavet Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2675488 | clotrimazole / gentamicin / mometasone Otic Suspension [Mometavet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2675489 | Mometavet 3 MG / 1 MG / 10 MG in 1 GM Otic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675489 | Mometavet 3 MG / 1 MG / 10 MG in 1 GM Otic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675489 | Mometavet 3 MG / 1 MG / 10 MG in 1 GM Otic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675560 | Teglutik | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675561 | riluzole 5 MG/ML [Teglutik] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675562 | Teglutik Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675563 | Teglutik Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675564 | riluzole Oral Suspension [Teglutik] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675565 | TEGLUTIK 5 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675565 | TEGLUTIK 5 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675565 | TEGLUTIK 5 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675565 | TEGLUTIK 5 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675567 | emicizumab-kxwh 12 MG in 0.4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675567 | emicizumab-kxwh 12 MG in 0.4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675567 | emicizumab-kxwh 12 MG in 0.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675568 | Hemlibra 12 MG in 0.4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675568 | Hemlibra 12 MG in 0.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675568 | Hemlibra 12 MG in 0.4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675568 | Hemlibra 12 MG in 0.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675569 | influenza A virus A/California/122/2022 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2675570 | influenza A virus A/California/122/2022 (H3N2) antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675573 | influenza virus vaccine 2024 southern hemisphere (quadrivalent - California/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675573 | influenza virus vaccine 2024 southern hemisphere (quadrivalent - California/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675573 | influenza virus vaccine 2024 southern hemisphere (quadrivalent - California/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675574 | influenza virus vaccine 2024 southern hemisphere (quadrivalent - California/Michigan/Phuket/Victoria) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675574 | influenza virus vaccine 2024 southern hemisphere (quadrivalent - California/Michigan/Phuket/Victoria) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675574 | influenza virus vaccine 2024 southern hemisphere (quadrivalent - California/Michigan/Phuket/Victoria) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675575 | Fluzone Quadrivalent 2024 Southern Hemisphere | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675576 | influenza A virus A/California/122/2022 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2024 Southern Hemisphere] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675577 | Fluzone Quadrivalent 2024 Southern Hemisphere Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675578 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2024 Southern Hemisphere] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675580 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine 0.7 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675580 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine 0.7 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675580 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine 0.7 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675581 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675581 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675581 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675583 | birch triterpenes | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2675584 | birch triterpenes 0.1 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675585 | birch triterpenes Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2675586 | birch triterpenes Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2675587 | birch triterpenes 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675587 | birch triterpenes 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675587 | birch triterpenes 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675588 | Filsuvez | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675589 | birch triterpenes 0.1 MG/MG [Filsuvez] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675590 | Filsuvez Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675591 | birch triterpenes Topical Gel [Filsuvez] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675592 | Filsuvez 10 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675592 | Filsuvez 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675592 | Filsuvez 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675592 | Filsuvez 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675594 | menthol 2 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675594 | menthol 2 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675594 | menthol 2 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675595 | Ceritant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2675596 | maropitant 16 MG [Ceritant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2675597 | Ceritant Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2675598 | Ceritant Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2675599 | maropitant Oral Tablet [Ceritant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2675600 | Ceritant 16 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675600 | Ceritant 16 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675600 | Ceritant 16 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675601 | maropitant 160 MG [Ceritant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2675602 | Ceritant 160 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675602 | Ceritant 160 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675602 | Ceritant 160 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675603 | maropitant 24 MG [Ceritant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2675604 | Ceritant 24 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675604 | Ceritant 24 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675604 | Ceritant 24 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675605 | maropitant 60 MG [Ceritant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2675606 | Ceritant 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675606 | Ceritant 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675606 | Ceritant 60 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675619 | hypromellose 2208 (4 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2675620 | temsavir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2675621 | LidoPro Pain Relieving Patch | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675622 | lidocaine 0.04 MG/MG / menthol 0.01 MG/MG [LidoPro Pain Relieving Patch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675623 | LidoPro Pain Relieving Patch Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675624 | lidocaine / menthol Medicated Patch [LidoPro Pain Relieving Patch] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675625 | LidoPro Pain Relieving Patch 4 % / 1 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675625 | LidoPro Pain Relieving Patch 4 % / 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675625 | LidoPro Pain Relieving Patch 4 % / 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675668 | influenza A virus A/California/122/2022 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675669 | influenza virus vaccine 2024 (quadrivalent - California/Victoria/Michigan/Phuket) 0.5 ML Prefilled Syringe, southern hemisphere | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675669 | influenza virus vaccine 2024 (quadrivalent - California/Victoria/Michigan/Phuket) 0.5 ML Prefilled Syringe, southern hemisphere | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675669 | influenza virus vaccine 2024 (quadrivalent - California/Victoria/Michigan/Phuket) 0.5 ML Prefilled Syringe, southern hemisphere | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675670 | influenza A virus A/California/122/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675671 | influenza A virus A/California/122/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2024 Southern Hemisphere] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675672 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675672 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675672 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675673 | influenza A virus A/California/122/2022 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2024 Southern Hemisphere] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675675 | influenza virus vaccine 2024 (quadrivalent - California/Victoria/Michigan/Phuket) Injectable Suspension, southern hemisphere | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675675 | influenza virus vaccine 2024 (quadrivalent - California/Victoria/Michigan/Phuket) Injectable Suspension, southern hemisphere | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675675 | influenza virus vaccine 2024 (quadrivalent - California/Victoria/Michigan/Phuket) Injectable Suspension, southern hemisphere | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675676 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2024 Southern Hemisphere] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675678 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675678 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675678 | Fluzone Quadrivalent 2024 Southern Hemisphere vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675679 | Thyrocryn | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2675680 | levothyroxine sodium 0.0022 MG/MG [Thyrocryn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2675681 | Thyrocryn Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2675682 | Thyrocryn Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2675683 | levothyroxine Oral Powder [Thyrocryn] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2675685 | THYROCRYN 1 GM per 453.6 GM Oral Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675685 | THYROCRYN 1 GM per 453.6 GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675685 | THYROCRYN 1 GM per 453.6 GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675685 | THYROCRYN 1 GM per 453.6 GM Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675687 | latanoprost acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2675739 | infliximab-dyyb 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675739 | infliximab-dyyb 120 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675740 | infliximab Pen Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2675740 | infliximab Pen Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675741 | infliximab-dyyb Pen Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675742 | inFLIXimab-dyyb 120 MG in 1 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675742 | inFLIXimab-dyyb 120 MG in 1 ML Pen Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675742 | inFLIXimab-dyyb 120 MG in 1 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675742 | inFLIXimab-dyyb 120 MG in 1 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675742 | inFLIXimab-dyyb 120 MG in 1 ML Pen Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675743 | inFLIXimab-dyyb 120 MG/ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675743 | inFLIXimab-dyyb 120 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675743 | inFLIXimab-dyyb 120 MG/ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675743 | inFLIXimab-dyyb 120 MG/ML Pen Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2675744 | Zymfentra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675745 | infliximab-dyyb 120 MG/ML [Zymfentra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675745 | infliximab-dyyb 120 MG/ML [Zymfentra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675746 | Zymfentra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675747 | infliximab Pen Injector [Zymfentra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675747 | infliximab Pen Injector [Zymfentra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675748 | infliximab-dyyb Pen Injector [Zymfentra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675749 | Zymfentra 120 MG in 1 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675749 | Zymfentra 120 MG in 1 ML Pen Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675749 | Zymfentra 120 MG in 1 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675749 | Zymfentra 120 MG in 1 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675749 | Zymfentra 120 MG in 1 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675750 | Zymfentra 120 MG/ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675750 | Zymfentra 120 MG/ML Pen Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2675750 | Zymfentra 120 MG/ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675750 | Zymfentra 120 MG/ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675751 | infliximab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2675751 | infliximab Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675752 | infliximab-dyyb Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675753 | inFLIXimab-dyyb 120 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675753 | inFLIXimab-dyyb 120 MG in 1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675753 | inFLIXimab-dyyb 120 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675753 | inFLIXimab-dyyb 120 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675753 | inFLIXimab-dyyb 120 MG in 1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675754 | inFLIXimab-dyyb 120 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675754 | inFLIXimab-dyyb 120 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675754 | inFLIXimab-dyyb 120 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675754 | inFLIXimab-dyyb 120 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2675755 | infliximab Prefilled Syringe [Zymfentra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675755 | infliximab Prefilled Syringe [Zymfentra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675756 | infliximab-dyyb Prefilled Syringe [Zymfentra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675757 | Zymfentra 120 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675757 | Zymfentra 120 MG in 1 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2675757 | Zymfentra 120 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675757 | Zymfentra 120 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675757 | Zymfentra 120 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675758 | Zymfentra 120 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675758 | Zymfentra 120 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2675758 | Zymfentra 120 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675758 | Zymfentra 120 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675759 | ibuprofen 97.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675760 | acetaminophen 325 MG / ibuprofen 97.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675760 | acetaminophen 325 MG / ibuprofen 97.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675760 | acetaminophen 325 MG / ibuprofen 97.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675760 | acetaminophen 325 MG / ibuprofen 97.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675761 | acetaminophen 325 MG / ibuprofen 97.5 MG [Combogesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675762 | Combogesic Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675763 | Combogesic Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675764 | acetaminophen / ibuprofen Oral Tablet [Combogesic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675765 | combogesic 325 MG / 97.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675765 | combogesic 325 MG / 97.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675765 | combogesic 325 MG / 97.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675765 | combogesic 325 MG / 97.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675766 | camphor 5 % / menthol 5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675766 | camphor 5 % / menthol 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675766 | camphor 5 % / menthol 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675767 | lidocaine hydrochloride 0.0388 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675768 | lidocaine hydrochloride 3.88 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675768 | lidocaine hydrochloride 3.88 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675768 | lidocaine hydrochloride 3.88 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675769 | lidocaine hydrochloride 0.0388 MG/MG [Lidotral] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675770 | lidocaine Topical Gel [Lidotral] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675772 | Lidotral 3.88 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675772 | Lidotral 3.88 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675772 | Lidotral 3.88 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675773 | menthol / petrolatum Rectal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2675774 | menthol / petrolatum Rectal Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2675775 | menthol 0.1 % / petrolatum 80 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675775 | menthol 0.1 % / petrolatum 80 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675775 | menthol 0.1 % / petrolatum 80 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675776 | menthol 7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2675777 | lidocaine / menthol Rectal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2675778 | lidocaine / menthol Rectal Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2675779 | lidocaine 5 % / menthol 0.7 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675779 | lidocaine 5 % / menthol 0.7 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675779 | lidocaine 5 % / menthol 0.7 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675780 | pantoprazole 0.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675781 | pantoprazole 40 MG in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675781 | pantoprazole 40 MG in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675781 | pantoprazole 40 MG in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675782 | pantoprazole 0.4 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675783 | pantoprazole 0.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675784 | pantoprazole 40 MG in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675784 | pantoprazole 40 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675784 | pantoprazole 40 MG in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675785 | pantoprazole 0.8 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675786 | pantoprazole 80 MG in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675786 | pantoprazole 80 MG in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675786 | pantoprazole 80 MG in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 267582 | Substance with oxazolidinone structure and antibacterial mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 267582 | Substance with oxazolidinone structure and antibacterial mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 267582 | Substance with oxazolidinone structure and antibacterial mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 267582 | Substance with oxazolidinone structure and antibacterial mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 267582 | Substance with oxazolidinone structure and antibacterial mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 2675860 | lifileucel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2675865 | lifileucel 576000000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675866 | lifileucel Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2675867 | lifileucel Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2675868 | lifileucel 72,000,000,000 CELLS in 125 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675868 | lifileucel 72,000,000,000 CELLS in 125 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675868 | lifileucel 72,000,000,000 CELLS in 125 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675869 | lifileucel 576000000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675870 | Amtagvi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675871 | lifileucel 576000000 CELLS/ML [Amtagvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675872 | Amtagvi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675873 | lifileucel Injection [Amtagvi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675874 | AMTAGVI 72,000,000,000 CELLS in 125 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675874 | AMTAGVI 72,000,000,000 CELLS in 125 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675874 | AMTAGVI 72,000,000,000 CELLS in 125 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675874 | AMTAGVI 72,000,000,000 CELLS in 125 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675875 | lifileucel 576000000 CELLS/ML Injection [Amtagvi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675875 | lifileucel 576000000 CELLS/ML Injection [Amtagvi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675876 | camphor 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675876 | camphor 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675876 | camphor 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675877 | firocoxib 9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2675878 | firocoxib Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2675879 | firocoxib Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2675880 | firocoxib 9 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675880 | firocoxib 9 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675880 | firocoxib 9 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675881 | Equicoxib | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2675882 | firocoxib 9 MG/ML [Equicoxib] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2675883 | Equicoxib Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2675884 | Equicoxib Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2675885 | firocoxib Oral Solution [Equicoxib] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2675886 | EquiCoxib 9 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675886 | EquiCoxib 9 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675886 | EquiCoxib 9 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2675887 | menthol 12.5 % / methyl salicylate 12.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2675887 | menthol 12.5 % / methyl salicylate 12.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2675887 | menthol 12.5 % / methyl salicylate 12.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2675983 | 4-hydroxycyclophosphamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2675984 | Aloe africana leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2675985 | enmetazobactam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2675986 | enmetazobactam 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2675987 | cefepime / enmetazobactam | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2675988 | cefepime / enmetazobactam Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2675989 | cefepime / enmetazobactam Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2675990 | cefepime / enmetazobactam 2.5 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2675990 | cefepime / enmetazobactam 2.5 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675990 | cefepime / enmetazobactam 2.5 GM Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2675991 | Exblifep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2675992 | cefepime 2000 MG / enmetazobactam 500 MG [Exblifep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2675993 | Exblifep Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2675994 | cefepime / enmetazobactam Injection [Exblifep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2675995 | EXBLIFEP 2.5 GM Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2675995 | EXBLIFEP 2.5 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675995 | EXBLIFEP 2.5 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2675995 | EXBLIFEP 2.5 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2676107 | Opill 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2676107 | Opill 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2676107 | Opill 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2676585 | clindamycin phosphate 1 % Twice-Daily Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2676585 | clindamycin phosphate 1 % Twice-Daily Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2676585 | clindamycin phosphate 1 % Twice-Daily Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 26766 | Gastrin III | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26766 | Gastrin III | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26766 | Gastrin III | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26766 | Gastrin III | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26766 | Gastrin III | Designated preferred name (PT) | NO | |
| RxCUI: 26766 | Gastrin III | Full form of descriptor (FN) | NO | |
| RxCUI: 2676752 | vitamin D5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2676752 | vitamin D5 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2676753 | zingiberensis saponin I | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2676754 | brompheniramine / dextromethorphan Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2676758 | brompheniramine maleate 4 MG / dextromethorphan hydrobromide 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2676758 | brompheniramine maleate 4 MG / dextromethorphan hydrobromide 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2676758 | brompheniramine maleate 4 MG / dextromethorphan hydrobromide 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2676759 | pegunigalsidase alfa-iwxj 5 MG in 2.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2676759 | pegunigalsidase alfa-iwxj 5 MG in 2.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2676759 | pegunigalsidase alfa-iwxj 5 MG in 2.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2676760 | ELFABRIO 5 MG in 2.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2676760 | ELFABRIO 5 MG in 2.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2676760 | ELFABRIO 5 MG in 2.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2676760 | ELFABRIO 5 MG in 2.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2676952 | ligustrazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2676953 | panaxynol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2676954 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG Oral Capsule) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 15 MG / doxylamine succinate 6.25 MG Oral Capsule) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2676954 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG Oral Capsule) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 15 MG / doxylamine succinate 6.25 MG Oral Capsule) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2676954 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG Oral Capsule) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 15 MG / doxylamine succinate 6.25 MG Oral Capsule) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2677 | Coenzyme-A transferase | Designated preferred name (PT) | NO | |
| RxCUI: 2677 | Coenzyme-A transferase | Full form of descriptor (FN) | NO | |
| RxCUI: 2677076 | Tripenicol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2677077 | undecylenic acid 250 MG/ML [Tripenicol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677078 | Tripenicol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2677079 | undecylenate Topical Solution [Tripenicol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2677081 | Tripenicol S 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677081 | Tripenicol S 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677081 | Tripenicol S 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677081 | Tripenicol S 25 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677082 | undecylenic acid 130 MG/ML [Tripenicol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677083 | undecylenate Topical Cream [Tripenicol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2677085 | Tripenicol C 13 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677085 | Tripenicol C 13 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677085 | Tripenicol C 13 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677085 | Tripenicol C 13 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677086 | petrolatum 0.865 MG/MG [Critic-Aid Clear Moisture] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677087 | Critic-Aid Clear Moisture 86.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677087 | Critic-Aid Clear Moisture 86.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677087 | Critic-Aid Clear Moisture 86.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677087 | Critic-Aid Clear Moisture 86.5 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677156 | Zituvimet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2677157 | metformin hydrochloride 1000 MG / sitagliptin 50 MG [Zituvimet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677157 | metformin hydrochloride 1000 MG / sitagliptin 50 MG [Zituvimet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2677158 | Zituvimet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2677159 | Zituvimet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2677160 | metformin / sitagliptin Oral Tablet [Zituvimet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2677160 | metformin / sitagliptin Oral Tablet [Zituvimet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2677161 | metformin hydrochloride / sitagliptin Oral Tablet [Zituvimet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2677162 | Zituvimet 50 MG / 1000 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677162 | Zituvimet 50 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2677162 | Zituvimet 50 MG / 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677162 | Zituvimet 50 MG / 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677163 | metformin hydrochloride 500 MG / sitagliptin 50 MG [Zituvimet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677163 | metformin hydrochloride 500 MG / sitagliptin 50 MG [Zituvimet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2677164 | Zituvimet 50 MG / 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677164 | Zituvimet 50 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2677164 | Zituvimet 50 MG / 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677164 | Zituvimet 50 MG / 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677165 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2677166 | influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2677167 | influenza B virus B/Michigan/01/2021 antigen 0.12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2677170 | influenza virus vaccine 2023-2024 high-dose (Darwin/Victoria/Michigan) Prefilled Syringe 0.5 ML | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2677170 | influenza virus vaccine 2023-2024 high-dose (Darwin/Victoria/Michigan) Prefilled Syringe 0.5 ML | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677171 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.12 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2677172 | Fluzone 2023-2024 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2677173 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.12 MG/ML [Fluzone 2023-2024] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677174 | Fluzone 2023-2024 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2677175 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2023-2024] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2677177 | Fluzone 2023-2024 high-dose vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677177 | Fluzone 2023-2024 high-dose vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677177 | Fluzone 2023-2024 high-dose vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677178 | Fluzone 2023-2024 high-dose vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2677178 | Fluzone 2023-2024 high-dose vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2677178 | Fluzone 2023-2024 high-dose vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 267741 | sennoside A&B, calcium salt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2677422 | polyglyceryl-4 polyricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2677425 | tislelizumab-jsgr | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2677426 | tislelizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2677427 | tislelizumab-jsgr 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2677428 | tislelizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2677429 | tislelizumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2677432 | tislelizumab-jsgr 100 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2677432 | tislelizumab-jsgr 100 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677432 | tislelizumab-jsgr 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677433 | tislelizumab-jsgr 10 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2677433 | tislelizumab-jsgr 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2677433 | tislelizumab-jsgr 10 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2677434 | Tevimbra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2677435 | tislelizumab-jsgr 10 MG/ML [Tevimbra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677436 | Tevimbra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2677437 | tislelizumab Injection [Tevimbra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2677439 | TEVIMBRA 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677439 | TEVIMBRA 100 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677439 | TEVIMBRA 100 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677439 | TEVIMBRA 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677440 | TEVIMBRA 10 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2677440 | TEVIMBRA 10 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2677440 | TEVIMBRA 10 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2677442 | Ormalvi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2677443 | dichlorphenamide 50 MG [Ormalvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677444 | Ormalvi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2677445 | Ormalvi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2677446 | dichlorphenamide Oral Tablet [Ormalvi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2677447 | ORMALVI 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677447 | ORMALVI 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677447 | ORMALVI 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677450 | influenza virus vaccine 2023-2024 (Darwin/Victoria/Michigan) 0.5 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2677450 | influenza virus vaccine 2023-2024 (Darwin/Victoria/Michigan) 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677450 | influenza virus vaccine 2023-2024 (Darwin/Victoria/Michigan) 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677451 | influenza virus vaccine 2023-2024 (Darwin/Victoria/Michigan) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2677451 | influenza virus vaccine 2023-2024 (Darwin/Victoria/Michigan) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2677451 | influenza virus vaccine 2023-2024 (Darwin/Victoria/Michigan) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2677452 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML [Fluzone 2023-2024] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677454 | Fluzone 2023-2024 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677454 | Fluzone 2023-2024 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677454 | Fluzone 2023-2024 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677455 | Fluzone 2023-2024 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2677455 | Fluzone 2023-2024 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2677455 | Fluzone 2023-2024 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2677457 | influenza virus vaccine 2023-2024 (Darwin/Victoria/Michigan) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2677457 | influenza virus vaccine 2023-2024 (Darwin/Victoria/Michigan) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677457 | influenza virus vaccine 2023-2024 (Darwin/Victoria/Michigan) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677458 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML [Fluzone 2023-2024] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677459 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone 2023-2024] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2677461 | Fluzone 2023-2024 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677461 | Fluzone 2023-2024 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677461 | Fluzone 2023-2024 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677462 | hydrocortisone acetate 1 % / lidocaine HCl 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677462 | hydrocortisone acetate 1 % / lidocaine HCl 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677462 | hydrocortisone acetate 1 % / lidocaine HCl 5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2677463 | menthol 2 MG [Ricola] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2677464 | Ricola 2 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2677464 | Ricola 2 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677464 | Ricola 2 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677515 | chlorhexidine gluconate 4 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2677515 | chlorhexidine gluconate 4 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2677515 | chlorhexidine gluconate 4 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2677516 | isopropyl alcohol 0.2 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2677517 | ethanol 55 % / isopropyl alcohol 20 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2677517 | ethanol 55 % / isopropyl alcohol 20 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2677517 | ethanol 55 % / isopropyl alcohol 20 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2677570 | flumethasone 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2677571 | flumethasone Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2677572 | flumethasone Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2677573 | flumethasone 0.5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2677573 | flumethasone 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2677574 | Bimasone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2677575 | flumethasone 0.5 MG/ML [Bimasone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2677576 | Bimasone Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2677577 | flumethasone Injectable Solution [Bimasone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2677578 | bimasone 0.5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2677578 | bimasone 0.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2677578 | bimasone 0.5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2677688 | hydrocortisone 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2677688 | hydrocortisone 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2677688 | hydrocortisone 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2677689 | tolnaftate Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2677690 | tolnaftate 1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2677690 | tolnaftate 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2677690 | tolnaftate 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 267798 | disodium pyrophosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 267874 | Sparteine sulfate | Designated preferred name (PT) | NO | |
| RxCUI: 267874 | Sparteine sulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 267874 | Sparteine sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26797 | hetacillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 26797 | hetacillin | Designated preferred name (PT) | NO | |
| RxCUI: 26797 | hetacillin | Full form of descriptor (FN) | NO |